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5INTRODUCTION
1.1 Bacterial Biofilm: general properties. In the environment, bacteria can live as
either single organisms (planktonic mode of life) or within a multicellular
community (sessile mode of life), known as biofilm. Within a biofilm, bacterial
cells are stuck to each other and encapsulated in a self­produced matrix of
extracellular polymeric substance (EPS) comprising polysaccharides, proteins,
lipids and extracellular DNA (Jakobsen et al., 2017). Biofilm development occurs
on both environmental abiotic surfaces and on biotic ones; due to this versatility to
colonize different types of surfaces, biofilm formation is a critical issue in many
fields including nosocomial and chronic infections (Karatan and Watnick, 2009),
marine biofouling, industrial and environmental protection (Bhinu, 2005). The
development of a biofilm, occurring under specific conditions, implies dramatic
physiological, metabolic and phenotypic changes which are regulated by genetic,
community and environmental factors. The switch from a planktonic cell to a sessile
one can be divided in five different phases. After the bacterium approached closely
to the surface reducing the motility (Fig. 1a), the cell may form a transient
association with the surface and/or other microbes previously attached (Fig. 1b).
Then the bacterium forms a stable association becoming a member of the
microcolony (Fig. 1c). Biofilm­associated cells start growing and the biofilm
acquires a three­dimensional architecture (Fig. 1d). Occasionally, the biofilm­
associated bacteria detach from the biofilm matrix (Watnick and Kolter, 2000)
becoming able to colonize a new microenvironment (Fig. 1e). Several biological
factors regulate each phases of biofilm formation process: the initial interaction with
the surface is promoted by force­generating structures such as type IV pili and
flagella. The bacterium differentiates into a biofilm­associated cell by blocking the
synthesis of factors destabilizing the biofilm, i.e. the flagellum, and by producing
exopolysaccharide, fimbriae and conjugative pili reinforcing the overall biofilm
structure (Watnick and Kolter, 2000). Moreover, the detachment step is dependent
on changes in the environmental conditions including starvation, change in carbon
source, increasing nitric oxide levels and/or iron limitations.
6Figure 1. The main phases of bacterial biofilm development. All the illustrations of each steps (a­e)
are also coupled with the equivalent photomicrograph of a biofilm of Pseudomonas aeruginosa
(Davies, 2003).
Bacteria growing within biofilm have several advantages in comparison to the
planktonic single­cell bacteria. Indeed, the biofilm formation enables bacteria to
resist to predation by eukaryotes which phagocytize free­living bacteria in the
environment as well as to evade immune response during human and animal
infections. In addition, biofilm guarantees cooperative benefits including an
increased tolerance to antimicrobials agents, longer survival period to
environmental stresses as well as the ability to acquire transmissible genetic
elements at accelerated rates (Tolker­Nielsen, 2014). For these reasons biofilms are
particularly difficult to eliminate by the host and to eradicate with antibiotic therapy.
Indeed two­thirds of bacterial infections are due to biofilms (Romling et al., 2012).
Both abiotic and biological surfaces in the human body is at risk of being colonized
by biofilms. For instance, indwelling devices, including urinary and intravascular
catheters, prosthetic heart valves, cardiac pacemakers, and contact lenses are
examples of colonized medical devices. In addition, biofilm colonize and infect
biotic surfaces including nose and throat, lungs, and the gastrointestinal and urinary
tracts. Infections of both abiotic and biological surfaces, often associated with
hospitalization, surgical intervention, and mortality, are difficult to eradicate with
traditional antibiotic strategies (Wolfmeier et al., 2017). Despite this, multi­drugs
antibiotic­based therapies have been shown to be more effective than monotherapies
7due to activity against multispecies biofilms (Herrmann et al., 2010). The lack of
antibiotic efficacy against bacterial communities is often attributed to restricted drug
accessibility within a mature biofilm. For these reasons, a deep knowledge about the
molecular and biological mechanisms involved in biofilm development is required
in order to develop new strategies eradicating biofilm infections. This process was
often described and studied using Pseudomonas aeruginosa, the etiological agent of
many chronic infections, as current biofilm model organism.
1.2 Pseudomonas aeruginosa as a model system for biofilm studies.
P. aeruginosa is Gram­negative bacterium studied as a reference model organism
for biofilm research. This bacterium is often found as an environmental isolate but
it can be an opportunistic pathogen involved in medical device­associated as well as
chronic infections. Indeed P. aeruginosa plays a key role in different human biofilm
infections including cystic fibrosis (CF) pneumonia, chronic bacterial prostatitis and
chronic wound infections (Rybtke et al., 2015). In particular, this bacterium is the
leading cause of death in CF patients. CF is a recessive genetic disease, affecting
1/2500 newborns in Europe (Moskowitz and Ernst, 2010), caused by mutation in the
cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR protein
regulates the transepithelial ion flow maintaining the physiological volume of
airway surface fluid: mutations in this gene lead to an accumulation of mucus inside
the lower respiratory tract (Gibson et al., 2003). The accumulation of mucus makes
the airways susceptible to chronic bacterial infections inducing an immune response
unable to eradicate the infections, finally resulting in the respiratory failure. Despite
inflammatory response and intensive antibiotic treatments, P. aeruginosa mediated
infections are difficult to be eradicated due to its robust biofilm. Specifically, the
bacterium goes through several modifications in order to survive in CF lung
microenvironment including adaptation to alginate overproduction, non­motility,
small­colony formation, modification of O­group chain of LPS and hypermutability
(Yang et al., 2011). In addition, the stagnant mucus in the lung epithelium
constitutes a nitrate­rich anaerobic environment and P. aeruginosa is able to
produce energy under anaerobic conditions using the metabolic pathway of
denitrification as well as the Arginine Deiminase (ADI) pathway (Lu et al., 2004).
8Since P. aeruginosa patho­physiological role in CF disease is closely related to its
ability to form biofilm, extending the knowledge concerning the molecular
mechanisms controlling this process is crucial to develop new antimicrobial
strategies.
1.3 Communication in a biofilm: Quorum sensing and Nucleotide Signalling.
The two systems regulating the formation of biofilm are the Quorum Sensing (QS)
and the nucleotide signalling systems (Landini, 2009). QS regulates gene expression
via the secretion and detection of small molecules known as autoinducers (AIs) to
perceive the population density. A low cell density determines a low concentration
of AIs. When bacteria accumulate, forming a minimal bacterial population called
quorum, the concentration of these signals increases. The detection of a threshold
concentration of AIs switches the expression of genes regulating several processes
such as virulence factors production, antibiotic resistance and biofilm formation
(Sifri, 2008 ; Sintim et al., 2010 ; Srivastava and Waters, 2012).
The other main player in biofilm formation is represented by the nucleotide­
mediated signalling (Fig. 2). Both linear as well as cyclic nucleotides act as
bacterial second messengers regulating the biofilm development. One of the first
nucleotide signalling molecules discovered in bacteria was the Alarmone
[guanosine­(penta)tetraphosphate, (p)ppGpp] acting as the global transcriptional
regulator upon amino acid starvation (Cashel and Gallant, 1969; Liu et al., 2015).
Several years later, bis­(3′­5′)­cyclic diguanosine monophosphate (c­di­GMP) was
firstly identified as the allosteric regulator of cellulose production by Benziman and
coworkers (Ross et al., 1987), but only in the last 20 years the role of c­di­GMP as
the main bacterial second messenger has been emerged. Among the Cyclic
Dinucleotide (CDN) signalling field there are two other signalling molecules: cyclic
di­AMP (c­di­AMP) and cGMP–AMP (cGAMP). The c­di­AMP signalling network
is involved in several cellular functions including DNA integrity, potassium
homeostasis, gene expression, biofilm formation and sporulation process in Bacillus
subtilis (Jenal et al., 2017). cGAMP metabolism is very intriguing because it is
produced by both bacteria and metazoans. Bacterial cGAMP has a 3′­3′ linkage and
was originally discovered in Vibrio cholerae as a signalling molecule required for
host colonization (Kato et al., 2015).
9Furthermore, numerous recent studies have demonstrated that cyclic dinucleotides
are potent immunostimulatory compounds since they can activate the STING
(STimulator of INterferon Genes) signalling pathway (Karaolis et al., 2007 ; Chen
et al., 2010 ; Jenal et al., 2017).
pGpG ppGpp pppGpp
C­di­GMP C­di­AMP 3'3' cGAMP
Figure 2. Chemical structures of the main bacterial second messengers
1.4 Cyclic di­GMP metabolism. Cyclic di­GMP, discovered as an allosteric factor
required for activation of cellulose biosynthesis in Gluconacetobacter xylinus (Ross
et al., 1987), is the most abundant bacterial second messenger. In the last 20 years,
the importance of c­di­GMP in the bacterial physiology raised up. Indeed, the
second messenger regulates many phenotypes including cell differentiation in
Caulobacter crescentus, the heterocyst formation in cyanobacteria, development
and antibiotic production in streptomycetes, long­term nutritional stress survival,
lipid metabolism and transport in mycobacteria (Römling et al., 2013).
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C­di­GMP is considered the intracellular signaling molecule regulating the biofilm
formation and dispersal in several bacteria species, including Salmonella enterica,
Escherichia coli, G. xylinus, V. cholerae and P. aeruginosa. A general principle is
that high c­di­GMP levels are associated to biofilm formation while low levels
promote biofilm dispersal (Antoniniani et al., 2013). However some exceptions of
this general mechanism are now emerging. As an example, P. aeruginosa biofilms
are estimated to contain on average 75–110 pmol of c­di­GMP per mg of total cell
extract, while planktonic cells are appraised to contain less than 30 pmol/mg (Basu
Roy and Sauer, 2014).
C­di­GMP regulates biofilm formation by producing extracellular matrix
components such as: exopolysaccharides, adhesive pili, curli fimbriae, adhesins as
well as extracellular DNA (Römling et al., 2012). Indeed c­di­GMP is able to
control biofilm­related targets at different levels including the transcriptional, post­
transcriptional and post­translational ones. Concerning the mechanism of c­di­GMP
mediated control of biofilm formation, the scenario is very complex. The c­di­GMP
molecule is characterized by an high degree of polymorphism which favours its
interaction with a large number of proteins and nucleic acids using different binding
modes (Fig. 3). In solution, c­di­GMP can exist in the monomeric, dimeric,
tetrameric and octameric form depending on its concentration and the presence of
metal ions. However, under physiological conditions, the main aggregation states
are a monomer in equilibrium with the intercalated dimer; both forms were
observed in crystal structures of c­di­GMP binding and metabolizing proteins (Chan
et al., 2004; Tchigvintsev et a., 2010; Shu et al., 2012) (Fig. 3).
A B
DGC Inhibitory site EAL active site
Figure 3. Polymorphism of c­di­GMP molecule. (A) 3D structure of monomeric and dimeric c­di­
GMP. The equilibrium in solution between these two species is influenced by the presence of
monovalent or divalent cations (Stelitano et al., 2013). (B) Heterogeneity of c­di­GMP binding to
proteins. C­di­GMP binds as intercalated dimer to the inhibitory site of DGC (left panel ; PDB
2V0N), while as a monomer to the active site of EAL PDE (right panel ; PDB 4LJ3).
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The monomer­dimer equilibrium likely plays a physiological role, allowing bacteria
to sense and to control different local c­di­GMP concentrations.
The intracellular levels of c­di­GMP are controlled by the rate of its synthesis and
degradation which are bidirectionally regulated by diguanylate cyclases (DGCs) and
phosphodiesterases (PDEs), respectively. The first group of enzymes produces c­di­
GMP and they are characterized by the structurally conserved domain GGDEF,
named from the strictly conserved signature (Gly­Gly­Asp­Glu­Phe) at the active
site. On the other hand, PDEs enzymes are divided in two groups: the first group of
enzymes, characterized by the consensus sequence EAL (Glu­Ala­Leu) responsible
for the hydrolytic activity, hydrolyses c­di­GMP to the linear dinucleotide pGpG;
the other group of PDEs named HD­GYP proteins (His­Asp and Gly­Tyr­Pro)
hydrolyses c­di­GMP directly to GMP. The distribution of c­di­GMP metabolizing
proteins among species of the same phylum is not homogenous: free living bacteria
with different environmental lifestyles carry more genes coding for putative c­di­
GMP metabolizing enzymes than obligate parasites (Galperin, 2005). Interestingly,
genomic database contains sequences of GGDEF and EAL domain proteins
encoded by plants and lower eukaryotes. While the function of plant GGDEF and
EAL domain proteins remains unknown, in the lower eukaryotes the c­di­GMP acts
as a developmental regulator (Chen and Schaap, 2012). The genome of P.
aeruginosa PAO1 encodes for 42 proteins likely involved in c­di­GMP metabolism,
in particular 18 GGDEF containing DGCs, 5 EAL containing PDEs, 16
GGDEF/EAL hybrid proteins, and 3 HD­GYP containing PDEs. In addition most of
these proteins often carry various sensory domains on their N­terminus, likely
participating in transduction of environmental stimuli, being c­di­GMP levels finely
controlled by different environmental settings (Ha and O’Toole, 2015). The first
data suggesting that c­di­GMP metabolism was a component of the cellular signal
transduction network derived from the presence of the GGDEF and EAL domains in
tandem with the oxygen­sensing PAS (Per­ARNT­Sim) sensory domain in DGCs
and PDE of G. xylinus (Chang et al., 2001). This discovery suggested a possible
modulation of enzymatic activity of the two domains by the upstream sensory
one(s).
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In particular these domains allow the proteins to perceive several signals such as:
nutrients (Paiardini et al., 2018), gases (O2, NO and CO) (Cutruzzolà and
Frankenberg­Dinkel, 2016), the redox state (Qi et al., 2009), light, quorum­sensing
molecules and many other signals (Henry and Crosson, 2011 ; Deng et al., 2012). In
addition, these c­di­GMP metabolizing proteins are often part of Two Components
System network since they can bear REC domain, modulating c­di­GMP levels in
response to signals received by their cognate sensor His kinases (Galperin, 2010).
Among the players involved in c­di­GMP network, the c­di­GMP receptors
represent an heterogeneus group of proteins. Indeed, the detection of c­di­GMP
levels within the cell and the resulting activation of a specific cellular signaling
pathway is mediated by both c­di­GMP effectors and receptors. In particular, c­di­
GMP effectors are proteins whose activity allosterically changes upon c­di­GMP
binding. This event induces effectors to undergo conformational changes,
transcriptional activation or repression, protein­protein interactions and enhanced
enzymatic activity. On the other hand, c­di­GMP receptors activate specific
signalling pathways after the c­di­GMP binding (Valentini and Filloux, 2016). Both
c­di­GMP receptors and effectors are able to interact with c­di­GMP through
different domains. Due to the absence of a common domain involved in c­di­GMP
recognition, the bioinformatic identification of proteins able to bind c­di­GMP
proved to be challenging. Since c­di­GMP can adopt different conformations, it can
interact with RNAs, as well as different classes of proteins (Römling et al., 2013).
Indeed, c­di­GMP receptors include riboswitches, transcription factors, PilZ domain
receptors, I­site receptors and inactive EAL/HD­GYP domain receptors.
Riboswitches are located in the 5’ untranslated regions of mRNAs (5’­UTR)
showing different conformations depending on c­di­GMP binding, which can
promote or inhibit transcriptional termination and translation (Hengge, 2016).
Among the c­di­GMP protein receptors, PilZ containing proteins are the most
studied. PilZ domain binds both monomers and dimers of c­di­GMP coupling the
sensing of c­di­GMP to several processes. Moreover degenerate catalytically
inactive GGDEF and EAL domains bind to c­di­GMP acting as receptors. For
instance, GGDEF containing protein PopA from C. crescentus binds c­di­GMP
regulating cell cycle (Duerig et al., 2009) as well as the inactive EAL containing
protein LapD from Pseudomonas fluorescens acts as a c­di­GMP receptor
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promoting the biofilm formation (Dahlstrom et al., 2015). The c­di­GMP network
properties, including different binding modes, multidomain metabolizing enzymes
and heterogeneous receptors (Fig. 4), suggest that c­di­GMP based physiological
responses are extremely sophisticated, making bacteria able to react to several
environmental conditions. Due to the high complexity of the c­di­GMP network, the
molecular details of c­di­GMP signalling are still fragmentary and few biochemical
and molecular data on proteins involved in c­di­GMP turnover are available
(Romling et al., 2013). A brief summary of so far available functional and structural
data of c­di­GMP enzymes is given below.
Figure 4.Main components of c­di­GMP metabolic and signalling network
1.4.1 Diguanylate Cyclases: the makers. The GGDEF domain was originally
described in 1995 by Hecht and Newton in the response regulator PleD from C.
crescentus (Hecht and Newton, 1995). PleD is a multidomain DGC characterized by
a REC1­REC2­GGDEF domain organization where the upstream receiver domains
regulate the downstream GGDEF activity. Structural and mechanistic studies on
PleD proposed insights about the modes of substrate binding, catalysis, enzyme
activation and inhibition (Chan et al., 2004 ; Wassmann et al., 2007). The c­di­GMP
formation is a two­step reaction requiring two molecules of GTP and resulting in
two molecules of pyrophosphate as reaction by­products. Two Mg2+ or Mn2+ cations
are required for phosphoester bond formation as well as the two GTP molecules
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Protein
PleD
PleD
(after dimerization)
C­di­GMP
(nmol min­1 mg­1)
3.32±(0.7)
159.97±(22.6)
Figure 5. PleD diguanylate cyclase. The quaternary structure of PleD with c­di­GMP bound is
reported on the left (the GGDEF domain is labeled in green while the REC1 and REC2 are labeled in
purple and pink, respectively). Once REC1 is phosphorilated, the dimerization process occurs,
increasing the rate of the enzyme, as indicated in the table on the right.
aligned in an antiparallel orientation. GGDEF domains function as homodimers
where both monomers contribute to the formation of the active site. The active site,
or A site, of the GGDEF domain is crucial for GTP binding. The GG(D/E)EF
signature forms an hairpin where the first two Gly and the third amino acid are
needed for catalysis and the Asp/Glu plays an additional role in metal coordination
while the forth Glu residue is the main amino acid involved in metal ion
coordination. Finally, the Phe residue plays a structural role, keeping the hairpin in
the position. The enzymatic regulation of this class of proteins is mediated by two
different mechanisms. The first mechanism requires conformational dimerization of
the GGDEF domains in response to changes in the sensory domains linked to the
GGDEF domains Indeed, the GGDEF dimerization process takes place after the
REC domain are phosphorylated through one of its cognate kinases (Paul et al.,
2004). Since the dimerization increases the enzymatic activity in comparison with
monomeric form of PleD, this implies that the phosphorylation­mediated
dimerization represents the main mechanism controlling PleD diguanylate cyclase
(Fig. 5 ; Paul et al., 2007).
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A further mechanism regulating the activation/inactivation of DGCs is based on a
feedback inhibition. The I­site, if present, is a functional motif comprising four
residues (RXXD where ‘X’ is any residue) located five amino acids upstream of the
GGDEF signature. C­di­GMP binds as an intercalated dimer to the I­site (Fig. 3B,
left panel) inducing an interlock between two either identical (i.e. GGDEF/GGDEF)
or different domains (i.e. GGDEF/REC, GGDEF/GAF, YcgR­N/PilZ). The c­di­
GMP binding to the I­site blocks the GGDEF movement required for the
homodimerization rearrangement thus hampering the catalytic activity. In PleD, the
binding of c­di­GMP to I­site induces structural rearrangements of GGDEF altering
kinetic parameters. Since each domain provides one of the two key arginines, in the
case of the I­site of DGCs the first arginine is provided by the primary I­site (Ip) of
the GGDEF domain (the conserved RxxD motif), while the second may be recruited
from the secondary I­site (Is) of another GGDEF domain or from a different one.
The c­di­GMP mediated feedback inhibition is the best understood example of the
allosteric regulation mediated by this second messenger.
An exception of this allosteric regulation is represented by YfiN from P. aeruginosa.
Despite the presence of a primary I­site, this protein does not undergo to a feedback
inhibition since it lacks of the additional secondary site required for I­site­dependent
feedback regulation. In this case, protein activation leading to the two GGDEF to be
faced requires the upstream HAMP domains transducing a periplasmic signal
(Giardina et al., 2013).
1.4.2 Phosphodiesterases: the breakers. A first general characterization of an
EAL­containing phosphodiesterases was performed by Benzimann and collegues in
1987 (Ross et al., 1987). This domain hydrolyzes c­di­GMP into linear 5’­pGpG
which is then degraded by different enzymes. The majority of EAL­containing
PDEs form dimers and this quaternary structure is critical for protein activation by
cellular and environmental stimuli. The dimerization interface is evolutionarily
conserved and it is formed by two helices and a long loop. Specifically, the α5 helix
is directly connected through loop 6 to two central Asp residues coordinating the
metal ions in the active site (Barends et al., 2009). This loop undergoes several
structural rearrangements and it can act as an hinge coupling the EAL conformation
to catalytic activity through the repositioning of metal ions within the active site.
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Figure 6. The EAL active site of RocR. The binding of the substrate requires the presence of two
cations (green spheres) involved in the coordination of water molecules. One water molecule is
involved in the hydrolytic attack on a phosphoester bond of the c­di­GMP.
This system, controlling the biofilm formation and virulence genes expression, is
composed of a membrane sensor RocS1 and two response regulators, RocA1 and
RocR. RocR activity is triggered by phosphorylation and the protein competes with
RocA1 for the phosphoryl transfer from the RocS1 sensor (Kulasekara et a., 2005).
The degradation of the pGpG produced by EAL containing enzymes is mediated by
different proteins. Specifically, the oligoribonuclease Orn, which hydrolyses
nanoRNAs (2–5 nucleotides in length), is the main enzyme able to degrade pGpG
(Orr et al., 2015).
Protein KM (µM) kcat (min­1)
RocR 3.2±0.3 0.67±0.03
Based on structural characterization of an EAL­containing PDE, several clues about
the c­di­GMP binding site and catalytic mechanism were obtained (Sundriyal et al.,
2014). EAL activity requires either Mn2+ or Mg2+ while it is inhibited by Ca2+: EAL
domain binds c­di­GMP monomer through two metal cations which are also
involved in coordination of two water molecules. One of this water molecules is
required for the hydrolytic attack on a phosphoester bond of the c­di­GMP. A higher
pH and the presence of Mn2+/Mg2+ promote the optimal bond lengths in the metal­
water cluster while Ca2+ distorts the distances inside the cluster resulting in an
inhibitory effect. Concerning the catalytic mechanism, the Glu residue within the
EAL motif is crucial for PDE activity: indeed, this residue is involved in
coordination of one of the metals inside the active side (Fig. 3B right panel). In P.
aeruginosa, the first EAL­containing PDE identified was RocR (Fig. 6), component
of the RocSAR signalling system.
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In addition, other enzymes are involved in the degradation of pGpG, including few
EAL PDE such as RbdA, which shows pGpG hydrolytic activity, named PDE­b
activity, and the second family of phosphodiesterases characterized by the HD­GYP
catalytic domain. In contrast to EAL­containing enzymes able to convert c­di­GMP
into the linear product pGpG, HD­GYP domain hydrolyses c­di­GMP producing
two molecules of GMP and this catalytic activity requires divalent cations, most
likely Mg2+ or Mn2+. This class of phosphodiesterase is not ubiquitous in bacteria
(Galperin, 2005). Bd1817, from Bdellovibrio bacteriovorus, is an unconventional
HD­GYP protein, lacking the active­site tyrosine present in the HD­GYP family
members, whose crystallographic structure revealed the fold of the HD­GYP
domain, together with some important clues about the catalytic and the regulation
mechanisms (Lovering et al., 2011). This enzyme shows a binuclear iron center into
the active site and sequence alignment revealed that the residues around this metal
center are structurally conserved also in the conventional HD­GYP proteins. Despite
this, the first structure of an active HD­GYP domain containing PDE indicated that
a trinuclear iron­binding site is required for its catalysis (Bellini et al., 2013). In
addition the active site is different from that observed in the EAL enzymes, since
the limited access to the active­site cleft suggests a different mechanism of activity
regulation. The genome of P. aeruginosa encodes for three HD­GYP containing­
proteins, PA4108, PA4781 and PA2572. Few in vivo and in vitro data describing
these enzymes are available. For instance, biochemical and structural data
concerning PA4781 showed that this enzymes has a bi­metallic active site,
hydrolyses c­di­GMP to GMP in vitro through a two­step reaction via the linear
intermediate pGpG, and this reaction is regulated upon the phosphorylation of the
upstream REC domain. Interestingly, this protein is able to degrade pGpG to GMP
and, moreover, PA4781 preferentially binds to pGpG over c­di­GMP, indicating that
both this protein may work as an unconventional HD­GYP phosphodiesterase and
that pGpG could act as a signalling molecule (Stelitano et al., 2013 ; Rinaldo et al.,
2015).
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1.4.3 Hybrid Proteins: the enzymatic conundrum. Genomic analysis revealed
that around 1/3 of all GGDEF domains and approximately 2/3 of all EAL domains
are found on the same polypeptide chain (Seshasayee et al., 2010). The existence of
hybrid proteins bearing both antagonistic catalytic domains implies an enzymatic
riddle regarding the final catalytic output. For this reason, the study of hybrid
proteins is really challenging. Two possibilities may explain the enzymatic
conundrum of hybrid proteins. One scenario is that both domains are enzymatically
active but they are differentially regulated by environmental and/or cellular signals
resulting in one prevalent activity. This first hypothesis is supported by MorA, the
first bifunctional hybrid protein characterized (Phippen et al., 2014) and MucR (Hay
et al., 2009) from P. aeruginosa. MorA is a dimeric membrane protein with PAS
sensory domains in the cytosolic portion which is followed by downstream GGDEF
and EAL domains. MorA shows both diguanylate cyclase and phosphodiesterase
activities and, in particular, the PDE activity is regulated by the GGDEF domain by
increasing the turnover rate of the enzyme (Fig. 8). The other example of hybrid
protein showing both DGC and PDE activities which are differently regulated is
MucR.
Figure 8. Monomer of MorA hybrid protein from P. aeruginosa. MorA bound c­di­GMP within the
active site of EAL domain (orange). The catalysis is regulated by the GGDEF domain (purple)
increasing the turnover rate of the enzyme (Phippen et al., 2014)
Protein
14 ± 1.4
PDE
turnover (%)
MorA
(GGDEF­EAL)
MorA
(EAL)
100 ± 8.8
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The GGDEF and the EAL domains of MucR are activated in different growth
phases: in planktonic cells, MucR DGC activity positively regulates alginate
biosynthesis while in biofilms, it functions as a PDE regulating the dispersal upon
the nitric oxide or glutamate exposure (Hay et al., 2009 ; Wang et al., 2015).
The other scenario is represented by hybrid proteins showing either one or both
GGDEF­EAL inactive domains which are still able to recognize the substrates as a
signal; signal recognition triggers an allosteric response such as conformational
changes or protein­protein interactions. In agreement with this possibility, there is
the example of the hybrid protein LapD from P. fluorescens. LapD is an inner­
membrane protein required for biofilm formation and maintenance. This protein has
degenerate and inactive GGDEF and EAL domains: the protein can bind c­di­GMP
but cannot synthesize or degrade it. When c­di­GMP is absent, LapD shows an
autoinhibited conformation where the upstream HAMP domain and the GGDEF
domain block c­di­GMP from accessing the EAL domain. In this autoinhibited state,
the periplasmic domain of LapD is involved in an uncompetent binding state with
the cysteine protease LapG. This interaction allows LapG to cleave LapA from the
cell surface preventing the biofilm formation early steps. Upon an increase in
cytoplasmic c­di­GMP, a large conformational change at the level of the GGDEF
and HAMP domains takes place, allowing the EAL domain dimerization. This
signal is transmitted to the periplasm where LapD interacts with LapG in a
competent way. After this protein­protein interaction, LapG is no longer able to
cleave LapA from the cell surface, resulting in biofilm formation by the activation
of different proteins involved in stable surface attachment (Newell et al., 2009 ;
Navarro et al. 2011).
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Figure 9. C­di­GMP­dependent regulation of the periplasmic protease LapG via the inner membrane
protein LapD. Conformational changes expose a periplasmic binding site for LapG on LapD
periplasmic PAS domain. In addition, c­di­GMP to the inactive EAL domain of LapD increases ~6
fold the apparent affinity for LapD, sequestering the protease away from its substrates, the adhesin
proteins LapA in P. fluorescens (Cooley et al., 2016).
Another example of protein belonging to this last group is the hybrid protein
CC3396 from C. crescentus. CC3396 shows only the EAL­dependent
phosphodiesterase activity while the GGDEF domain lacks enzymatic activity.
Interestingly, the GGDEF domain is able to bind GTP within the A­site and this
binding triggers PDE activation by lowering the KM for c­di­GMP of EAL domain
(Christen et al., 2005), suggesting that the GGDEF domain is involved in an
allosteric regulation of the EAL catalytic activity via GTP molecule.
Despite the relevance of these proteins considering their involvement in pathogenic
settings and the intriguing allosteric control of their activity, few mechanistic data
are available in the literature.
1.5 The regulation of c­di­GMP signalling. The extraordinary large number of
proteins involved in c­di­GMP network in many bacterial species suggests that c­di­
GMP signalling network is complex. Indeed, these networks include enzymes,
receptors and effectors which are able to sense and respond to both cellular and
environmental cues, adjusting the c­di­GMP levels in order to control a specific
phenotypic output. All these observations lead to an open question: how is a
bacterial cell able to coordinate several proteins involved in c­di­GMP metabolism
and signalling?
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To solve this issue, several models have been proposed to explain how c­di­GMP
signalling networks control specific effector proteins at the right time or location
within the bacterial cell. One model, called 'Affinity Model', depends on binding
affinity of different effectors to c­di­GMP. In P. aeruginosa affinity differences
greater than 140­fold among its eight PilZ domain­containing proteins were found
(Christen et al., 2010; Pultz et al., 2012). According to this affinity model, global
pools of c­di­GMP modify expression and activity of c­di­GMP­metabolizing
enzymes (Krasteva et al., 2010 ; Hickman et al., 2008). Frequent observations
showing that genetic deletion of a particular DGC or PDE can lead to a specific
phenotype despite the apparent redundancy of DGCs and PDEs in single species has
reinforced the hypothesis about a ‘local signalling’ of c­di­GMP based on spatial
distributions of c­di­GMP metabolizing proteins. This hypothesis implies the
presence of protein­protein interactions among DGCs, PDEs, and effectors, spatially
close to each other, allowing local signaling. Consistent with this 'Local Model',
different in vivo evidences have been found in several bacterial species including
Yersinia pestis, E. coli and P. fluorescens (Bobrov et al., 2008 ; Lindenberg et al.,
2013 ; Dahlstrom et al., 2015). Regardless the signalling model proposed, the c­di­
GMP network, controlling several cellular functions, is regulated at multiple levels:
allosteric regulation of an enzyme activity or protein function, regulation of gene
expression via the modulation of a transcription factor and as well as via direct
interaction with noncoding RNA molecules, i.e. riboswitches. As described above,
the c­di­GMP metabolizing enzymes can be subjected to an allosteric regulation
mediated by a plethora of mechanisms and small molecules (Chan et al., 2004 ;
Wassmann et al., 2007 ; Newell et al., 2009 ; Navarro et al. 2011 ; Christen et al.,
2005). In addition, the c­di­GMP signalling has a key role in transcriptional
regulation of genes involved in biofilm development and dispersal. An example of
transcriptional circuit affected by c­di­GMP is represented by the transcriptional
factor BrlR from P. aeruginosa. BrlR is an Helix­Turn­Helix (HTH) transcriptional
factor belonging to the MerR family of multidrug transport activators which
contributes to the drug tolerance of P. aeruginosa biofilms. This protein is able to
bind its own promoter regulating its expression. Interestingly the BrlR­DNA
interaction is enhanced upon the c­di­GMP binding, contributing to brlR expression
(Chambers et al., 2014) which, in turn, promotes multidrug resistance in biofilm.
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C­di­GMP signalling is also involved in regulation of the protein translation through
small non­coding RNAs called riboswitches. Riboswitches are a 5′ UTR elements of
bacterial mRNAs and consists of two different modules: the aptamer and the
expression domains. The aptamer module binds different ligands triggering a
conformational change on the expression domain that directly modulate the
translation of the downstream open reading frame (ORF). In V. cholerae, the Vc2 c­
di­GMP riboswitch has two possible secondary structures: a ligand­bound state
which blocks the initiation of translational and a free ligand state which activates
translational beginning. Upon c­di­GMP binding to aptamer module, the Vc2
riboswitch secondary structure undergoes to a conformational change masking of
Ribosome Binding Sequence (RBS) (Inuzuka et al., 2018).
1.6 The role of nutrients on c­di­GMP signalling and metabolism. In addition to
these regulatory strategies, c­di­GMP metabolizing enzymes are controlled by
environmental cues including nutrients levels. In P. fluorescens, several groups of
genes are regulated under different nutrient conditions, suggesting that the the
nutrient­dependent regulation may be an efficient method to control the c­di­GMP
network by controlling single proteins under specific environmental conditions
(Dahlstrom et al., 2018). However, little is known about how nutrients involved in
biofilm development are perceived and how signaling pathways translate these cues
into the modulation c­di­GMP levels. It has been established that the switch
between a free living cell to a sessile one occurs as a response to the availability of
nutrients. Indeed, nutrient­depleted environments favour the biofilm formation
while the biofilm dispersion occurs in response to a change in the nutrient
composition. In particular, it has been demonstrated that the availability of nutrients
at high concentration represses the formation of biofilms favouring the detachment
(Rochex and Lebeault, 2007). All these observations suggested that bacteria
perceive the availability of nutrients in the environment through a variety of
complex regulatory networks likely regulating the c­di­GMP metabolism in a
nutrient­dependent way (Sauer et al., 2004). Despite the well established link
between nutrients availability and biofilm development, few molecular data are
available concerning both the expression of c­di­GMP related genes as well as the
regulation of c­di­GMP metabolizing enzymes in response to nutrients.
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For instance, transcription of the rapA gene, encoding for a hybrid protein of P.
fluorescens showing only PDE activity, has been demonstrated to be upregulated
when cells are grown in a low phosphate medium (Monds et al., 2007). Another few
examples of the role of nutrients as regulators of c­di­GMP signalling were
described in V. cholerae. When the bacterium reaches the stomach, during its
infectious process , the exposure to bile acids induces the activation of three DGCs,
CdgH, VC1372, and CdgM, leading to an increase of c­di­GMP concentration
(Conner et al., 2017). Moreover, polyamines, within the human gastrointestinal
tract, represent another environmental signal involved in c­di­GMP metabolism in V.
cholerae. Norspermidine and spermidine regulate in an opposite way biofilm
formation controlling the membrane­bound phosphodiesterase MbaA and its
periplasmic partner NspS. Norspermidine binds to NspS which interacts with the
periplasmic portion of MbaA blocking its PDE activity. This signalling pathway
triggers biofilm formation. On the other hand, spermidine blocks biofilm
development and this repression occurs via competition with norspermidine for
NspS binding site (Goforth et al., 2013). In P. aeruginosa, glutamate plays a role in
biofilm dispersal modulating c­di­GMP levels. This metabolite is at the crossroad
between anabolism and catabolism, playing a role in cell division during amino acid
starvation via ppGpp (Sperber and Herman, 2017). NicD is a transmembrane
GGDEF diguanylate cyclase participating in a complex signaling mechanism. This
diguanylate cyclase is activated upon the binding of glutamate and this event
triggers a signalling cascade resulting in the activation of the phosphodiesterase
DipA, which reduces c­di­GMP levels (Basu Roy et al., 2014). In addition to
glutamate, arginine has a crucial role in P. aeruginosa metabolism. This bacterium
is able to use this amino acid as source of carbon, energy and nitrogen, via a
complex metabolic network (Fig. 10). This amino acid can be catabolized by
arginine deiminase (ADI) producing ATP under low oxygen tension and this
enzyme is inducible by exogenous L­arginine (Lu etal., 2004). Moreover,
environmental L­arginine plays a key role in chronic infections, virulence and
antibiotic resistance in P. aeruginosa biofilm (Schreiber et al., 2006; Son et al.,
2007; Barbier et al., 2014; Peng et al., 2017).
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At molecular level, extracellular L­arginine controls the production of phenazines
(Ha et al., 2011) which in turn modulates biofilm formation through the second
messenger c­di­GMP (Okegbe et al., 2017). Despite the presence of L­arginine
sensory systems involved in the regulation of c­di­GMP levels have been proposed
(Mills et al., 2015; Romling et al., 2015), little is known about the genes involved in
these signalling pathways in P. aeruginosa (Rinaldo et al., 2018).
These few examples clearly underline that different nutrients, energy source and
environmental conditions have strong effects on biofilm development and
homeostasis, controlling at different levels the c­di­GMP signalling network.
These mechanisms of regulation (nutrient input, transcriptional regulation, protein­
protein and protein­ligand interactions) work in combination finely controlling the
c­di­GMP network and providing both specificity and fidelity to the system.
Figure 10. Schematic representation of L­arginine metabolic pathways. The pathways present in P.
aeruginosa are indicated with continuous lines; the dashed line indicates the utilisation of arginine to
produce NO by bNOS (Rinaldo et al., 2018).
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AIM OFTHEWORK
In developed countries, more than 60% of human chronic infections are caused by
bacterial biofilm. These communities are difficult to eradicate since they show an
high resistance to both antimicrobials agents and host immune system response.
One of the most important factor controlling this process is the bacterial second
messenger 3’,5’­cyclic diguanylate (c­di­GMP). For this reason, a deep knowledge
about the c­di­GMP signalling and metabolism is crucial to develop new therapeutic
approaches against bacterial biofilm.
Given that nutrients are among the major driving forces guiding the change of c­di­
GMP levels, the characterization of the mechanistic details linking nutrients sensing
to c­di­GMP homeostasis is very interesting and up to now poorly characterized. In
particular my project has been focused on the characterization of the Hybrid
Protein RmcA from Pseudomonas aeruginosa. The aim of study was to identify a
putative protein in P. aeruginosa able to link the nutrient state to c­di­GMP
signalling. To identify the best canditate we looked for a GGDEF­EAL protein
harbouring the Venus Fly Trap (VFT) domain, one of the most representative fold
among proteins involved in periplasmic nutrients perceiving. The Gram negative P.
aeruginosa is the leading agent of nosocomial infections and the main cause of
death in cystic fibrosis (CF) patients. The genome of P. aeruginosa encodes for
proteins involved in c­di­GMP metabolism harbouring the GGDEF and/or the EAL
signatures. Among these, rmcA (Redox modulator of c­di­GMP) gene encodes for a
protein harbouring a periplasmic VFT sensory domain, a transmembrane helix,
three Per­Arnt­Sim (PAS) domain and one light, oxygen, or voltage domain (LOV)
and finally the GGDEF­EAL domains. Recent studies demonstrate that the deletion
of this gene in P. aeruginosa PA14 strain affected the bacterial swarming and
swimming motility (Okegbe et al., 2017). Few structural data are available on this
family of enzymes and these data indicate that the output of this class of proteins is
regulated by a reciprocal allosteric control between the two GGDEF and EAL
domains occuring via inter­domain interactions and ligand­induced conformationals
changes. In addition, the final output is difficult to predict since it depends also on
the interaction between the two domains and the upstream sensing/regulatory ones.
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In the light of this, the biochemical characterization of this protein has been divided
in three different tasks:
• The identification of the environmental signal controlling the RmcA output. This
goal was reached following an interdisciplinary approach including bioinformatics,
biophysics and microbiology. Bioinformatic preliminary data identified the putative
signal perceived by the sensory domain and this interaction was confirmed by
Isothermal Titration Calorimetry (ITC). Moreover, we observed that this
environmental signal triggered the protein activation in vivo in P. aeruginosa PAO1
strain.
• The unveiling of the mechanistic details of PDE catalysis control. Combining
bioinformatics, enzyme kinetics, biophysics and structural biology, we characterized
the biochemical properties of the GGDEF­EAL containing region of RmcA
(hereinafter DUAL). DUAL has a phosphodiesterase catalytic output EAL­
dependent which is regulated by the upstream GGDEF inactive domain.
• The role of LOV domain in controlling the PDE catalysis and signal transduction.
Since the catalytic output of hybrid proteins is strongly regulated by the upstream
domains, we characterized the biochemical properties of DUAL upstream LOV
domain in order to assess its putative role in phosphodiesterase activity regulation.
This goal was tested combining bioinformatics, enzyme kinetics and biophysics
approaches.
During the enzymatic characterization of RmcA, we observed alternative and novel
reactivity of the GGDEF domain which has been analysed more deeply, also in
comparison with other GGDEF­containing enzymes. We found that DUAL protein
showed an unusual catalytic activity converting GTP to GMP. We therefore
investigated whether this unexpected feature is a common feature of different
GGDEF containing proteins, including both DGCs and hybrid proteins. In DGCs,
this side­activity occurs when the physiological diguanylate activity does not take
place, due to either GGDEF dimerization issues or constitutive inactivation of DGC
activity. On the other hand, in the hybrid proteins tested in this study, the unusual
GTPase activity seems to compete with the main phosphodiesterase activity. This
side project has been useful for the overall study presented in this PhD thesis, since
it allowed us to establish the best experimental conditions to study this domain,
since literature data describing GGDEF domian are really fragmentary.
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The data obtained in this PhD research project allowed us to improve the knowledge
concerning the regulation of GGDEF­EAL hybrid proteins, so far poorly
characterized biochemically. In particular, the identification of the environmental
signal perceived by the N­terminal sensory domain of RmcA represents a novel
mechanism of metabolite sensing important for c­di­GMP metabolism. In addition,
combining structural biology, protein engineering and enzyme kinetics, we
described an allosteric mechanism regulating the phosphodiesterase output of RmcA
and we showed a novel unusual kinetic activity of the GGDEF domain.
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MATERIALSAND METHODS
3.1 Proteins expression and purification. RmcA gene was amplified by PCR from
genomic PAO1 DNA and subcloned (NdeI/BamHI) as N­terminal His­tag construct
in Pet28b (hereinafter RmcA FL; residues 1­1245). In addition, some constructs of
RmcA were obtained by PCR of a synthetic construct of rmcA (GeneArt) encoding
for the last 554 amino acid residues and subcloned as N­terminal His­tag constructs
in Pet28b. From these templates, the fragments listed in Fig. 10 were coned. In
addition, the constructs encoding for other c­di­GMP metabolizing enzymes,
previously available in the laboratory, were tested (Fig. 10).
Figure 10. Domain organization of Full Length RmcA protein from P. aeruginosa. From the RmcA
FL template, several constructs were obtained and characterized. In addition, constructs encoding for
DGC enzymes and Hybrid Proteins were kinetically analyzed.
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Site­directed mutants were obtained using the Quikchange Lightning kit (Agilent
Technologies, Santa Clara, CA) according to the manufacturer's instructions;
mutagenesis were confirmed by DNA sequencing. All constructs were
overexpressed in the E. coli BL21 (DE3) strain. Bacterial cultures were grown at
37°C in Luria­Bertani (LB) liquid medium supplemented with 30 μg/ml Kanamycin
(Sigma). When OD 600 was about to 0.8, the temperature was reduced to 20°C and
protein expression was induced by adding 0.5 mM IPTG (isopropyl Β­d­
thiogalactoside; Sigma). Cells were harvested by centrifugation after 20 hours and
stored at ­20 °C. All bacterial pellets were suspended in lysis buffer and then they
were lysed by sonication. After centrifugation, the proteins were purified by affinity
chromatography using a HisTrap column (GE Healthcare) loaded with Ni2+ and
equilibrated with Buffer A, specific for each protein (Table I). Elution was carried
out increasing the imidazole concentration, with the proteins eluting at 150­300 mM
imidazole range. Fractions containing pure protein were pooled, imidazole was
removed with PD­10 desalting columns (GE Healthcare) and concentrated with
Ultracel Amicon® concentrators. FL protein was only partly purified for a
preliminary characterization. The other proteins were loaded on different FPLC
columns, according to their molecular weights, and eluted with buffer A using an
FPLC apparatus (AKTA system) (Table 1). Purified proteins were flash frozen in
liquid nitrogen and stored at −20°C and the protein content was evaluated with BCA
assay (Sigma­Aldrich) and spectroscopically. When affordable the Molar Extinction
coefficient (ε) was calculated by BCA.
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Name Lysis Buffer Buffer AFPLC Column ε (mg∙ml­1)
FL 250 mM NaCl, 50 mM Tris­
HCl pH 8, 1 mM PMSF,+2%
v/v Tween®20 1 cOmplete
protase inhibitor (Roche)
(20 mM Tris­HCl
pH 7.5, 250 mM
NaCl, +2% v/v
Tween®20
// 2.13
VFT ; LOV 250 mM NaCl, 50 mM Tris­
HCl pH 8, 1 mM PMSF and 1
cOmplete protease inhibitor
(Roche)
Superdex
75
0.9 ; 1.3
LOV­DUAL 50 mM NaCl, 50 mM Tris­
HCl pH 8, 1 mM PMSF and 1
cOmplete protease inhibitor
(Roche)
20 mM Tris­HCl
pH 7.5, 300 mM
NaCl
20 mM Tris­HCl
pH 8.5, 150 mM
NaCl
0.97Superdex
200
DUAL;
EAL­1;
EAL­2
250 mM NaCl, 50 mM Tris­
HCl pH 8, 1 mM PMSF and 1
cOmplete protease inhibitor
(Roche)
20 mM Tris­HCl
pH 7.6, 150 mM
NaCl
PleD
YfiN
20 mM Tris–HCl pH 8.0, 50
mM NaCl, 1 mM PMSF and 1
cOmplete protease inhibitor
(Roche)
250 mM NaCl, 10 mM Tris­
HCl pH 8, 10% v/v Glycerol,
2 mM PMSF and 1 cOmplete
protease inhibitor (Roche)
100 mM NaCl, 20
mM Tris–HCl pH
8.0
250 mM NaCl, 10
mM Tris­HCl pH 8,
10% v/v Glycerol
Superdex
200
Superdex
200
Superdex
200
0.6 ; 0.83 ;
0.93
0.3
0.3
Table I. Details on composition of lysis buffer, buffer A and FPLC columns used to purify each
construct.
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3.2 Kinetic assay: PDE activity. PDE activity was evaluated by reverse­phase
high­performance liquid chromatography (RP­HPLC), as previously described
(Stelitano et al., 2013), to set the optimal buffer conditions and to probe the effect of
the different nucleotides and non­hydrolyzable GTP analogues (Jena Bioscience) on
PDE activity. To study the phosphodiesterase activity of the different purified
constructs, a 1 µM enzyme solution was incubated at 25°C in 20 mM Tris­HCl pH
8, 100 mM NaCl, 2.5 mM MnCl2 and 80 µM GTP. The reaction was started after the
addition of 30 µM c­di­GMP and it was stopped at selected times by adding 150 µl
of 50 mM EDTA pH 6.0 and boiled at 95°C for 10 min. Reactions were centrifuged
for 10 min at 13000 rpm and the protein precipitate was removed with 0.2 μm filters
(Bilk GHP Acrodisc 13mm). The reactions products were separated using a 150 x
4.6 mm reverse phase column (Prevail C8, Grace Davison Discovery Science,
particle size of 5 µm) with 100 mM phosphate buffer pH 5.8/ methanol (98/2, v/v, 1
ml/min) a mobile phase and set the UV detector at 254 nm. Data are the mean of
two experiments ± SD. Real­time kinetics of PDE activity were assayed by circular
dichroism (CD), as previously published (Stelitano et al., 2013). Briefly, protein
solution (1 µM) in 20 mM Tris­HCl pH 8.0, 100 mM NaCl and 2.5 mM MnCl2 was
incubated 10’ at 25°C; if indicated, the mixture was further incubated 5’ at 25°C
with 50 µM GTP (or the concentration indicated for the GTP­dependence) prior the
addiction of c­di­GMP; the reaction was carried out in 1 cm path quartz cuvette in
800 µl of final volume and followed for 10 min. C­di­GMP degradation was
monitored following the CD signal at 282 nm, using a JASCO J­710
spectropolarimeter at 25°C. The values are the means of data from at least three
independent experiments, and the errors are ± SD. The c­di­GMP content was
extrapolated by using the calibration curve of c­di­GMP previously obtained. These
data were used for the Michaelis­Menten plot; for DUAL E890A fit of kinetic data
were carried out with the substrate inhibition equation, using a simple model where
binding of a second molecule of substrate to the Michaelis­Menten complex yields a
dead­end state:
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The hyberbolic trend of V0 PDE (with 30 µM c­di­GMP) as a function of [GTP]
was fitted with the binding equilibrium equation:
3.3 Kinetic assay: GTPase activity. The GTPase activity of different RmcA­
derived constructs as well as of PleD, YfiN was analyzed using RP­HPLC. RmcA­
derived constructs and YfiN (10, 8 or 5 µM, as indicated) in 20 mM Tris­HCl pH
8.0, 100 mM NaCl and 2.5 mM MnCl2 were incubated with 100 µM GTP and the
reaction mixture was kept at 25°C for different time intervals. The rates of
hydrolase activity were also assayed in the presence of 30 or 60 µM c­di­GMP, if
indicated. To test the putative GTPase activity of PleD, 5 µM of enzyme in 20 mM
Tris­HCl pH 8, 100 mM NaCl and 10 mM MgCl2 was incubated for 10 minutes at
room temperature. The DGC activity of the enzyme was then activated by adding 10
mM NaF and 1 mM BeCl2 and kept at room temperature for 30 minutes. To avoid
DGC enzyme activation, the inactive form of the enzyme was obtained by not
adding BeCl2. Both catalytic reactions were then performed at 25°C adding 100 µM
GTP. All the reactions, which were carried out with different enzymes, were stopped
and the nucleotide content was separated and detected as described above.
3.4 Optimization of GMP separation by RP­HPLC. To assess the identity of the
GTPase activity product, we optimized the RP­HPLC separation. We separated the
unknown species using a 150 x 4.6 mm reverse phase column (Prevail C8, Grace
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3.5 Isothermal Titration Calorimetry (ITC) assays. Isothermal titration
calorimetry (ITC) experiments were carried out using an iTC200 microcalorimeter
(MicroCal). Parameters of the different titrations are reported in Table II. All
titrations were carried out using both ligands and proteins in the corresponding
buffer A, indicated in Table I. ITC data were analyzed by integrating the heat
exchange for each addition and normalized for the amount of injected protein. The
heat of binding (H), the stoichiometry (n), and the dissociation constant (KD) were
then calculated from plots of the heat evolved per mole of ligand injected versus the
molar ratio of ligand to protein using the Origin software provided by the vendor
(single binding site equation). Data are the mean of at least three experiments ±SD.
Protein
VFT 32 µM
DUAL 35 µM
(± 25 µM GTP)
EAL­2 25 µM
LOV 10.3 µM
Ligand
Amino Acids
600 µM
C­di­GMP
390 µM
C­di­GMP
195 µM
FAD,FMN,PYO
149.2 µM
Injection Volume Injection time
interval
Temperature
1.2 µl
1.2 µl
2 µl
1.5 µl
200 sec
180 sec
300 sec
180 sec
25°C
25°C
25°C
25°C
Table II. Details on ITC parameters applied to assay the binding properties of RmcA­derived
constructs.
Davison Discovery Science, particle size of 5 µm). Due to the incompatibility of
100 mM phosphate buffer with MS analysis, catalytic products were eluted with
0.1% Formiate/Methanol (98/2, v/v, 0.3 ml/min) a mobile phase, setting the UV
detector at 254 nm. The product eluted was lyophilized and Mass Spectrometry
analysis was done in collaboration with Prof. Cappellacci from University of
Camerino. HPLC­DAD­ESI­TRAP studies were performed using an Agilent 1100
series and an Ion Trap LC/MSD Trap SL G2445D from Agilent Technologies (Santa
Clara, CA, USA) equipped with an ESI source operating in negative ionization
mode.
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3.7 Fluorescence experiments. Titration of DUAL, EAL­1 and EAL­2 constructs
with MANT­GTP and MANT­c­di­GMP (Life Technologies) was assayed on a
Fluoromax­4 single photon counting spectrofluorometer (Horiba JobinYvon).
Briefly, protein tryptophans were excited at 280 nm and the fluorescence emission
spectra were recorded between 400 and 550 nm, as a result of Förster Resonance
Energy Transfer (FRET) to MANT­GTP or MANT­c­di­GMP (in 1 cm light path;
Hellma), after 3 min of incubation with the fluorophore. The binding of the
fluorophores with each proteins was tested in 20 mM Tris­HCl pH 7.6, 150 mM
NaCl and 2.5 mM CaCl2 at 25°C in a final volume of 500 µl.
3.6 Experiments in the presence of FAD. Flavin Adenine Dinucleotide (FAD)
reconstitution experiments were performed using 10 µM of LOV­DUAL or DUAL
protein in buffer A. Absorbance spectra of each construct were acquired before the
reconstitution. Then, both protein were incubated with 30 µM of FAD in
corrisponding buffer A for 120 minutes at 25°C. After this incubation, unbound
FAD was removed using a PD Minitrap G­25 and the absorbance spectra were
recorded to establish the presence of bound FAD. The titration of LOV construct
with FAD was tested by fluorescence experiments performed as described by
Sengupta and coworkers (Sengupta et al., 2012). Briefly, the FAD fluorescence
emission quenching at 535 nm was recorder upon the addition of increased amounts
of LOV protein. The time course phosphodiesterase activity in presence of FAD was
tested in both anaerobic and aerobic conditions using RP­HPLC. Low oxygen
tension was established by flushing with nitrogen for 30 minutes the 0.66 µM LOV­
DUAL solution in 20 mM Tris­HCl pH 8, 100 mM NaCl, 2.5 mM MnCl2 with 100
µM FAD and/or 100 µM GTP and the same PDE buffer containing 30 µM c­di­
GMP as substrate. Both solutions were fluxed wit nitrogen keeping them into gas
thight cuvettes. Subsequently, the PDE buffer containing the c­di­GMP with FAD
and/or GTP was inserted into a glass micro cylinder closed with a gas thight rubber
cup, previously fluxed with nitrogen, and the protein solution was added, diluting
the LOV­DUAL solution to 0.33 µM final concentration. Reactions were kept at
25°C for different time intrvals, they were stopped and the nucleotide content was
separated and detected as described above.
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3.8 MANT­GTP Displacement. The displacement of MANT­GTP was carried out
following the decrease of fluorescence of the DUAL/MANT­GTP complex (1 µM
and 5 µM, respectively) in 20 mM Tris­HCl pH 7.6, 150 mM NaCl and 2.5 mM
MnCl2 upon the addition of increased amounts of GTP, GTPαS and GTPγS. The
maximum of the emission spectrum was used as fluorescence signal for
displacement plot, once the value was baseline corrected. For displacement
experiments, data were fitted with the following displacement equation:
Where x is the concentration of each GTP species used for the displacement
experiments, fx is the fluorescence signal at each GTP addition, f0 the fluorescence
of the MANT­GTP/DUAL complex when no competitor is present, fbott is the
fluorescence of 5 µM MANT­GTP in the presence of the maximal concentration of
of GTP species used for each displacement; data fit was corrected for the slope of
the free MANT­GTP signal. Kapp is the displacement constant, corresponding to
the concentration of competitor required to obtain 50% of displacement. Kapp is
dependent on KD_GTP, KD_MANT­GTP and [MANT­GTP] used in the assay according to
the following equation:
FRET experiments were performed titrating 2 µM of each proteins with MANT­
GTP or MANT­c­di­GMP at different increasing concentrations and the spectra
were baseline corrected by subtracting the buffer from the raw data.
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RESULTS and DISCUSSION
4.1 In vitro characterization of the VFT domain of RmcA. The biochemical
characterization of RmcA started from the study of its N­terminal sensory domain in
order to identify the putative signal recognized from this hybrid protein. According
to the RmcA domain organization, reported in Fig. 10, the periplasmic region
(residues 23­274) could be likely involved in signal recognition and transduction.
For this reason the periplasmic region of RmcA (residues 21­255) was cloned,
expressed and purified as indicated in Materials and Methods. At the same time,
Prof. Paiardini (‘La Sapienza’ University, Rome, Italy) performed a bioinformatic
analysis on this domain of RmcA, which suggested that this region contains a VFT
domain involved in signal recognition and transduction. The VFT domain, present
in Periplasmic Binding Proteins (PBPs), can recognize a wide spectrum of nutrients
including mono­ and oligosaccharides, amino acids, oligopeptides and other
nutrients. An homology model of the VFT domain of RmcA was built in order to
describe the structure­function relationships of this domain and to identify the signal
controlling RmcA activity (Paiardini et al., 2018). In silico analysis strongly
suggested that the VFT domain of RmcA could bind L­arginine through different
residues. In particular, Asp44 participates in ion­pair and ion­dipole interactions
with L­arginine, while the the aromatic rings of Trp47 and Trp86 are involved in π­
stacking with guanidinium group of the bound L­arginine (Fig. 11). These
interactions are also crucial for the binding of L­arginine into the VFT domain of
AncQR (Clifton and Jackson, 2016), supporting the scenario that RmcA could
perceive the presence of L­arginine via its VFT domain.
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Figure 11. Homology model of the periplasmic Venus Flytrap (VFT) domain of RmcA and L­
arginine binding pocket. (A) Cartoon representation of the VFT domain. Polar interactions between
L­arginine and the protein moiety are shown in yellow. The corresponding positions of AncQR from
E. coli (PDB: 4ZV1) are represented as transparent pink sticks. (B) Structural superposition between
the L­arginine binding pocket in VFT model of RmcA (green sticks) and AncQR (pink sticks).
Residues are labelled according to sequence numbering. Nitrogen and oxygen atoms are colored blue
and red, respectively. Figures adapted from Paiardini et al., 2018.
To confirm the in silico homology model, a biochemical analysis was performed on
this domain. The VFT domain is monomeric in solution regardless of the presence
of L­arginine in the buffer (Fig. 12A). Moreover, the excess of L­arginine results in
a slight but significant increase of the thermal stability of the protein (Fig. 12B)
suggesting that an interaction between the VFT and this amino acid could take
place.
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Figure 12. Structural properties of VFT. (A) Size–exclusion chromatography on a Superdex S200
10/30 column (Amersham). Chromatographic profiles of VFT samples eluted with 100 mM NaCl, 50
mM Tris pH 8.5 (continuous line) or in the presence of 1 mM L­arginine in the same buffer (dashed
line), the latter after incubation of VFT with L­arginine for 10 minutes, at room temperature. L­
arginine does not alter chromatographic profile of VFT, the elution volume is compatible with the
monomeric protein. (B) Thermal denaturation profile of 12 µM VFT (in 150 mM NaCl, 50 mM
Na/phosphate buffer pH 8.0 with or without 100 µM L­arginine, dashed and continuous lines,
respectively). The Thermal melting has been followed on a circular dichroism JASCO J­710
spectropolarimeter in a 1 mm quartz cuvette (Hellma) at 220 nm. The melting curves were obtained
increasing the temperature from 20°C to 90°C, with a constant rate of 1°C/min and data pitch of 1°C.
Figures adapted from Paiardini et al., 2018.
The interaction between the VFT of RmcA and L­arginine was assessed by
Isothermal Titration Calorimetry (ITC). VFT binds L­arginine with a KD=11.9±0.9
µM and a stoichiometry of 0.8±0.1 per monomer (Fig. 13A) and the measured
affinity is of the same order of magnitude of that of the structural template AncQR
(KD_VFT=11.9 vs KD_AncQR=5.7 µM). The binding is highly specific for L­arginine,
since no other amino acids such as lysine, leucine or glutamic acid could bind to this
domain (Fig. 13A). To further validate the structural properties of L­arginine
binding, the residues Asp44 and Trp47, predicted to be crucial for the interaction,
were mutated into Ala and Leu, respectively. As expected, this double mutation
completely abolishes the ability of VFT to bind L­arginine (Fig. 13B), confirming
the predicted binding mode.
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Figure 13. Binding of L­arginine to purified VFT. (A) Isothermal Titration Calorimetry (ITC) was
carried out by titrating a VFT with different amounts of L­arginine at 25 °C in corrispondent Buffer
A. To verify the specificity of binding, wild­type VFT was titrated with other amino acids, as
indicated in the figure legend, under the same experimental conditions. Data were fitted with the
single binding site equation with the Origin software, as provided by the vendor (continuous line),
yielding the following parameters: n=0.8±0.1; KD=11.9±0.9 µM; ΔH=­4.3±0.3 kcal/mol; ΔS=8.0±0.9
cal/mol/deg. (B) Titration was repeated with the D44A/W47L double mutant of VFT, under the same
experimental conditions. Figure adapted from Paiardini et al., 2018.
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4.2 RmcA responds to L­arginine modulating c­di­GMP levels. To test the
possible effect of L­arginine in modulating RmcA activity in vivo, the intracellular
levels of c­di­GMP were indirectly evaluated using an ad hoc biosensor (Pawar et
al., 2016). Our collaborator Dr. Rampioni (Roma Tre University, Rome, Italy) and
his group used the wild type P. aeruginosa PAO1 and ∆rmcA mutant strain deleted
in the rmcA gene for phenotypic characterization. C­di­GMP levels are 50% higher
in the ∆rmcA strain relative to wild type when L­arginine is used as carbon source
and this phenotype is complemented by the constitutive expression of RmcA via the
pUCP18­derived plasmid prmcA (Fig. 14A). As expected, when using M9 medium
supplemented with lysine, glutamic acid, or leucine as sole carbon sources, no
significant difference is observed between the wild­type and ∆rmcA mutant (Fig.
14A). These data indicated that likely RmcA is involved in lowering c­di­GMP
levels, and therefore it is likely a PDE responsive to arginine. In line with our
observations, the recent characterization of RmcA counterpart in PA14 strain
showed that indeed this protein is a PDE even though the environmental cue
controlling its activity was not identified (Okegbe et al., 2017). Since a reduction in
intracellular c­di­GMP levels negatively affects biofilm formation (Römling et al.,
2013), we analyzed the effect triggered by L­arginine and the other amino acids on
the biofilm formation in PAO1 wild type and ∆rmcA strains. Using L­arginine as
sole carbon source, biofilm adhesion units were ~12% higher in PAO1 ∆rmcA
respect to PAO1 wild type, while ~35% lower in PAO1 ∆rmcA carrying the prmcA
plasmid compared to the same mutant strain carrying the empty vector pUCP18
(Fig. 14B). As previously showed for the c­di­GMP levels, no phenotypic
differences are observed when lysine, glutamic acid, or leucine are used as carbon
sources (Fig. 14B). Our in silico data proposes that RmcA binds to L­arginine via its
VFT domain and this binding triggers the protein activation resulting in a reduction
of c­di­GMP levels and of biofilm formation in vivo, strongly suggesting that RmcA
acts as a PDE. In accordance with these data, we found that in vitro the partially
purified full­length RmcA protein shows the PDE activity, but not a significant
DGC one (Fig. 14C). These findings support the idea that RmcA is a sensory one­
component system coupling the L­arginine sensing and the intracellular levels of the
second messenger c­di­GMP.
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Figure 14. RmcA acts as a PDE in vivo and in vitro. (A) The c­di­GMP levels were evaluated using
PcdrA::lux reporter system in the indicated strains using M9 minimal medium supplemented with 20
mM of different amino acids, as indicated in the figure legend, as sole carbon sources. PcdrA::lux
activity was calculated as RLU normalized to A600. (B) For biofilm formation assays, wild type and
∆RmcA strains containing or not the pUCP18 empty vector or pRmcA plasmid were grown in M9
minimal medium supplemented with 20 mM L­arginine, L­lysine, L­glutamic acid or L­leucine as
** ** **
** ** ****
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sole carbon sources. Biofilm adhesion units were calculated as A595 normalized to A600. (C) Pilot
enzymatic assays on partially purified full length RmcA. The nucleotide content of the reaction
mixture, containing RmcA in the presence of excess GTP ( dashed line), or c­di­GMP (continuous
line), was separated by RP­HPLC to assess either the DGC or the PDE activity, respectively. While
the PDE reaction yields the expected product (i.e. pGpG), no c­di­GMP accumulates starting from
GTP, under these experimental conditions. Figures adapted from Paiardini et al., 2018.
4.3 GTP is an allosteric regulator of the RmcA PDE activity. To confirm the
phosphodiesterase catalytic output of RmcA protein suggested by in vivo
experiments, we produced different constructs bearing both putative catalytic
GGDEF and EAL domains (DUAL) or only the EAL domain with or without the
upstream hinge helix (EAL­1 and EAL­2, respectively) (Fig. 10). Given that the
signature sequences of both GGDEF and EAL domains were conserved, in principle
the DUAL construct is competent to carry out both the DGC and the PDE catalytic
activities. We found that the DUAL protein is able to convert c­di­GMP into pGpG
in vitro and this PDE activity is a feature of the EAL domain, in both the EAL­1 and
EAL­2 constructs (Fig. 15A). In addition, under the same experimental conditions,
the DUAL construct did not show neither a DGC activity nor a PDE­b activity, i.e.
hydrolytic conversion of pGpG into GMP (Stelitano, 2013), using GTP as the sole
substrate (Fig. 15B). Interestingly, the presence of excess GTP upregulates the PDE
activity of DUAL (Fig. 15C and 15D ; Table III); this kinetic enhancement occurred
also when GTP is added during c­di­GMP hydrolysis, confirming that a c­di­GMP
feedback inhibition does not take place (Fig. 15E). Moreover, this positive effect
induced by GTP is specific since GDP, ppGpp and pppGpp are unable to trigger
EAL activation to the same extent (Fig. 15F).
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Figure 15. RmcA GGDEF­EAL construct is a GTP­dependent PDE. (A) Pilot enzymatic assays
of the RmcA catalytic constructs. The nucleotide content of the reaction mixture, containing DUAL
incubated with excess of GTP (bold line), or with excess of c­di­GMP (thin line), to assess the either
the DGC or the PDE activity, respectively, was separated by RP­HPLC. While the PDE reaction
yields the expected product (i.e. pGpG), no c­di­GMP production was detected starting from GTP,
under these experimental conditions. The PDE activity was also detected on EAL­2 (dashed line) and
EAL­1 (dotted line) incubated with excess c­di­GMP. (B) Nucleotide content of the reaction of
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DUAL with c­di­GMP at different time (30’, 60’, 120’). Arrows indicate the consuption of c­di­GMP
and the production of pGpG while no GMP accumulates. (C) PDE activity of each construct carried
out in the presence of c­di­GMP as substrate with or without GTP (white and red bars, respectively).
Values are normalized to the activity without GTP. (D) Determination of the kinetic parameters of
DUAL. The PDE activity of DUAL was characterized both in the presence and in the absence of
GTP (initial rate, V0, red and black circles, respectively) as function of c­di­GMP concentration; data
were fitted with the Michaelis­Menten equation (continuous line). (E) PDE time­course of DUAL
and c­di­GMP: after 10 min from the beginning of the kinetics, GTP was added and kinetics
followed for further 5 min (continuous trace). The increased rate of c­di­GMP consumption due to
GTP addition is comparable to that observed when DUAL is incubated with excess GTP from the
beginning of the kinetics (dotted trace). (F) PDE activity was carried out in the presence of different
nucleotides, indicated in the X­axis. Values are normalized to the activity with GTP. Figures adapted
from Mantoni et al., 2018
The GTP allosteric regulation of the PDE activity of DUAL requires the GGDEF
domain. We used MANT­GTP (Biolog) as a fluorescent GTP analogue to find, by
FRET spectroscopy, that GGDEF binds GTP with a 1:1 stoichiometry (one
molecule/monomer). The nucleotide targets specifically the GGDEF since no
binding occurs performing the titration with EAL construct (Fig. 16A); we also
observed that the presence of excess c­di­GMP has no effect on MANT­GTP
binding (Fig. 16B). The MANT­GTP titration by FRET spectroscopy was carried
out using different amonuts of DUAL protein (Fig. 16C). We observed that the
amount of MANT­GTP required to saturate the protein, reaching the fluorescent
plateau, depends of DUAL concentration: this profile is typical of a titration plot
indicating that DUAL protein shows a sub­micromolar affinity to MANT­GTP (Fig.
16C).
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FRET displacement experiments showed that GTP displaces MANT­GTP,
confirming the sub­µM affinity also for the physiological GTP ligand (Fig. 17A).
Moreover, kinetic experiments indicated that the PDE activity shows an hyperbolic
dependence on GTP concentration in the tested range (2­50 µM, Fig. 17B), with an
apparent KD_app=2.8±0.5 µM. In contrast to the observed sub­µM binding affinity,
the maximal GTP­mediated PDE activation is obtained when GTP concentration is
above ~15 µM (Fig. 17B); this result implies that the GTP­dependent
phosphodiesterase activation (measured by the KD_app) requires additional events
after the GTP binding, likely a conformational change between an inactive to an
active form (OFF → ON). In agreement with this scenario, GTP enhances the Vmax
of the PDE reaction while KM for c­di­GMP is not affected (Table III), indicating
that the GTP increases the population of the catalytically competent PDE enzyme
(i.e. the ON form).
Figure 16. Binding of GTP to DUAL domain. (A) Comparison of the binding curve of MANT­
GTP to DUAL (red circles) and EAL­2 (black circles). No binding was observed with the latter
construct. (B) Titration of DUAL with MANT­GTP (red circles) yields a stoichiometry ratio of 1
GTP:1 DUAL monomer; the same profile was observed in the presence of excess c­di­GMP (black
circles). On the Y­axis is reported the FRET signal at 430 nm normalized for the plateu value (100%
of bound species) at given ligand concentration. The plateau value is considered as the Y­intercept of
the line parallel to X­axis fitting the plateau points. (C) Flurescence profiles of MANT­GTP titration
performed with different amounts of DUAL protein, as indicated in the legend. Figures adapted from
Mantoni et al., 2018
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RmcAConstruct
DUAL
DUAL E890A
//EAL­2
GTP (µM)
//
4
8
50
//
50
5.9±0.8
KM_C­di­GMP (µM)
4.1±0.4
2.5±0.9
4.2±1.2
2.5±0.5
11.6±3.5
9.6±0.1
kcat (min­1)
0.09±0.02
0.2±0.1
0.3±0.2
0.35±0.01
0.66±0.2
0.1 *
0.54 *
Table III. Comparison of the kinetic parameters different RmcA constructs. The GTP­
dependent kinetic regulation is mediated by both lowering the KM for the substrate as well as by
increasing the turnover rate of the enzyme. * To fit these data, the Vmax parameter has been imposed;
this value falls within the range of the Vmax observed for the wild­type construct. This constraint
represents the hypothetical Vmax of catalysis, if the substrate inhibition does not take place. For this
reason, it is not a real Kcat but an extrapolated Vmax, yielding the KM values reported in the table.
Data fit has been done considering one monomer of the EAL as the active site, to simplify the model.
BA
Figure 17. GTP binding effects on DUAL PDE kinetics. (A) Binding of GTP to DUAL was
assayed by displacement of MANT­GTP. The competition experiment was carried out in the presence
of a constant concentration of MANT­GTP and increasing competitor concentrations; buffer
conditions are those optimized for PDE activity. Data were fitted (continuous lines) with the
displacement equation, reported in Materials and Methods section, yielding the following Kdispl:
6.9±0.1 µM for GTP. At this stage we cannot extrapolate the precise Kd for each competitor, since we
do not know the exact Kd_MANT­GTP. (B) The PDE activity was assayed at different GTP
concentrations; the ratio V0 obs/Vmax as a function of GTP concentration is reported (black circles).
Data were fitted with the reversible binding equation (continuous line). Figures adapted from
Mantoni et al., 2018
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Using ITC and FRET spectroscopy, we described the c­di­GMP binding to the EAL
domain (EAL­2). As acknowledged by the literature, the first points of the titration
have not been considered in the fit, being biased by the endothermic contribution
due to c­di­GMP dilution into the cell (Matsuyama et al., 2016), c­di­GMP binding
to EAL domain shows one binding site per monomer yielding a KD_c­di­GMP=171±30
nM (Fig. 18, panels A­B, including ITC and FRET data, respectively). Interestingly,
the ITC titration of DUAL/c­di­GMP interaction shows a V­shaped titration profile
which is indicative of sequential binding events, including the dilution of c­di­GMP
and, probably, a conformational transition occurring upon binding. Due to the
complex ITC profile of DUAL/c­di­GMP interaction, we described this binding by
FRET spectroscopy using MANT­c­di­GMP (Biolog), a fluorescent analogue of c­
di­GMP. The FRET titration shows a sub­µM affinity for MANT­c­di­GMP and
0.6:1 stoichiometry (Fig. 18B). To confirm that MANT­c­di­GMP binds specifically
to the EAL active site, MANT­c­di­GMP titration was carried out also with the
DUAL double mutant D1136N­D1137N, in which the mutations alter the key
residues involved in metal­dependent binding of c­di­GMP to EAL active site. As
expected, the double mutation (D1037N/D1038N) abolishes the c­di­GMP binding,
confirming that this nucleotide targets only EAL domain (Fig. 18B). To describe the
allosteric regulation mediated by GTP, we tested the c­di­GMP binding to EAL
domain in the presence of GTP. Interestingly, the pre­incubation of DUAL with
excess of GTP changes the stoichiometry of binding of MANT­c­di­GMP from
0.6:1 to 1:1, as in EAL/c­di­GMP FRET titration, while the ITC profile does not
change significantly (Fig. 18B and 18C). Both kinetic and binding data indicated
that the DUAL PDE activity is enhanced upon the presence of GTP which is able to
change c­di­GMP binding stoichiometry, likely through a conformational
rearrangement.
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Figure 18. Binding of C­di­GMP to DUAL domain. (A) Binding of c­di­GMP to EAL­2 (open
circles) and to DUAL (black squares) was assayed by ITC; the heat exchange/mol of injectant has
been reported in the figure and data were fitted with a single binding site equation. (B) Binding of
MANT­c­di­GMP to DUAL and EAL­2 (black and empty circles, respectively) assayed by FRET
titration. The titration of DUAL was performed also after pre­incubation with GTP (red circles); the
MANT­c­di­GMP titration was carried out also with the DUAL double mutant D1136N­D1137N
(hereinafter DUAL_DD) and no significant binding is observed, (green circles). On the Y­axes, the
% of FRET signal at 430 nm is reported considering the plateau value as 100 %. (C) Binding of c­di­
GMP to DUAL as assayed titrating DUAL with c­di­GMP, with or without incubation with GTP (red
and black circles, respectively). ITC was also carried out with the mutant DUAL_DD (green circles).
Figures adapted from Mantoni et al., 2018.
4.4 Effect of the GTP binding on DUAL structure. Dr. Giardina and Dr. Brunotti
('La Sapienza' University of Rome) solved the structure of the DUAL construct in
complex with two molecules of GTP and five calcium ions at 2.8 Å resolution.
DUAL crystallized as an asymmetric dimer: the orientation of the GGDEF domain
with respect to the EAL domain is very different between the two monomers (Fig.
19A and 19B). In monomer­A, the GGDEF and EAL domains are spatially closer
(closed conformation) as compared to the other chain where the two domains are
more distant (monomer­B, open conformation). The fold of the GGDEF and EAL
domains is conserved in both monomers and the structural superposition of the two
EAL domains suggests that the conformational change is achieved via a rigid body
movement involving the connecting helix.
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Figure 19. Structure of DUAL. (A) Structure of the DUAL asymmetric dimer (PDB: 5M3C). In
each monomer the N­terminal GGDEF (blue), the connecting helix (red) and the EAL domain
(yellow) are highlighted in different colours while the GTP molecules and calcium ions are shown as
spheres. Superposition of the two monomers showing the conformational differences in the relative
orientation of the GGDEF domain with respect to the EAL domain. The bending of the connecting
helix and the corresponding shift of helix α1, belonging to the EAL domain, is highlighted in the
blow­up. (B) The c­di­GMP binding site. Superposition of the EAL domain of RmcA­DUAL (open
monomer, yellow) with the homologue hybrid protein from P. aeruginosa MorA in complex with c­
di­GMP and two Mg2+ ions (Phippen et al., 2014 ; 4RNH, violet). One guanine docks in a
hydrophobic cleft flanked by helix α1 and in the closed conformation the shift of this helix seals the
cleft, making c­di­GMP binding impossible. Figures adapted from Mantoni et al., 2018.
This asymmetric structure of DUAL, where only one subunit is competent for
substrate binding (monomer­B), explains the observed stoichiometry of MANT­c­
di­GMP binding to DUAL (~0.6 molar ratio). Since DUAL is fully saturated by
MANT­c­di­GMP in the presence of GTP, binding of the latter to GGDEF domain
induces a conformational change likely opening the active site in the EAL domain
(monomer­B like conformation). In agreement with this interpretation, an increase
of the DUAL volume in solution upon GTP binding is also observed by Dynamic
Light Scattering and Analytical Size Exclusion Chromatography (Fig. 20A and 20B,
respectively).
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Figure 20. Structural effects of GTP on DUAL. (A) Dynamic light­scattering measurements.
Hydrodynamic radius (Rh) and number distribution (Pn) of the 4 μM protein in the PDE buffer, both
in the absence and in the presence of GTP at a final concentration of 50 μM. Both conditions have
been tested twice, and each measurement is the result of the average of 24 consecutive
measurements. Measurements were carried out with a Zetasizer Nano S (Malvern Instruments,
Malvern, UK) equipped with a 4 mW He–Ne laser (633 nm), at 25°C, at an angle of 173°C from the
incident beam. Peak­intensity analyses were used to determine hydrodynamic radius number
distribution (Pn). (B) Size­exclusion chromatography on Superdex S200 10/30 (Amersham) on
FPLC apparatus. Chromatographic profiles of DUAL samples eluted with 20 mM Tris pH 7.6, 150
mM NaCl, 2.5 mM MnCl2, 2.5 mM MgCl2 (red line) or in the presence of 300 µM GTP in the same
buffer (blue line), the latter after incubation of DUAL with GTP for 10 minutes. GTP triggers a
population of DUAL (GTP­bound) with a significantly higher hydrodynamic volume than the GTP­
free form. Figures adapted from Mantoni et al., 2018.
All the results presented so far show that GTP binding to the GGDEF domain
triggers a significant effect on the overall conformation of DUAL, clarifying the
basis of GTP­dependent regulation of phosphodiesterase activity. Since GTP binds
to both open and closed monomer, the asymmetric dimer of DUAL may indeed
represent two intermediate snapshots of the events following GTP binding and
leading to the fully active ON species.
4.5 Analysis of GTP binding properties in the GGDEF active sites. To develop a
model of the GTP­dependent allosteric activation of RmcA, the open and closed
conformations of DUAL (Fig. 19A) was analysed to model the dimeric ON and
OFF states, respectively. In the closed conformation (monomer­A), the α1­helix of
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Figure 21. GTP likely triggers EAL­displacement. GTP bound to the GGDEF domain in the open
monomer (right) and to the closed monomer (left).The closed monomer contains two calcium ions
(Ca1 and Ca2), while in the open subunit only one ion is observed, in the same position
corresponding to Ca1. Figure adapted from Mantoni et al., 2018.
To confirm this hypothesis, we tested whether the GTP­α­S, whose binding
geometry is different from the GTP one, promotes the PDE activation likewise the
GTP. As expected, the α­substitution does not reproduce the positive effect of GTP
on PDE activity. In addition the α­substitution reduces DUAL affinity for GTP
(Kdispl:14.6±0.6 µM for GTP­α­S in contrast to Kdispl:6.9±0.1 µM for GTP). On the
other hand, the GTP­γ­S promotes PDE activation to the same extent of GTP and
this γ­substitution enhances DUAL affinity for GTP (Kdispl: 3.3±0.1 µM for GTP­γ­
S in contrast to Kdispl:6.9±0.1 µM for GTP) (Fig. 22A and 22B). The GTP­α­S
analogue affects MANT­c­di­GMP binding, whose titration resembles
the EAL domain is close to the GTP binding site of the GGDEF domain (Fig. 21).
In this position, the negatively charged residues of the α1­helix may interact with
the metals in the active site of the GGDEF domain, stabilizing the OFF
conformation. Structural and in silico analysis indicated that the binding of GTP
may, therefore, trigger the PDE catalysis of DUAL via the displacement of EAL
domain releasing the GGDEF­EAL interaction and allowing the monomer to
achieve the ON conformation. This large conformational rearrangement likely needs
the reorganization of the GTP molecule in the GGDEF binding site, mainly at the
level of the α­phosphate.
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that observed without GTP (Fig. 22C). Thus, these data indicates that the α­
substitution likely alter the geometry of binding thus hampering the formation of a
PDE­catalitically competent conformation; this observation confirm our structural
hypothesis showing that the GTP α­moiety is crucial to trigger EAL unlocking and
dimerization.
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Figure 22. The α­phosphate moiety is crucial to trigger GTP­dependent PDE activation. (A)
PDE activity of DUAL at 30 min after substrate addition carried out with c­di­GMP and, when
indicated, with either GTP or GTP­α­S or GTP­γ­S; pGpG content was determined by RP­HPLC.
Values are normalized considering the activity with GTP the maximal one (100%). (B) Binding of
GTP and its analogues to DUAL assayed by displacement of MANT­GTP. The competition
experiment was carried out in the presence of a constant concentration of MANT­GTP and various
competitor concentrations (i.e. GTP, red circles; GTP­γ­S, white circles; GTP­α­S, black circles);
buffer conditions are those optimized for PDE activity. (C) Titration of DUAL with different
amounts of MANT­c­di­GMP in the presence of GTP­α­S (open circles) is compared with the
experiments carried out with or without GTP (black and red circles, respectively). On the Y­axes, the
% of FRET signal at 430 nm is reported considering the plateau value as 100 %. Data are the mean
of three independent experiments ± standard deviation. Figures adapted from Mantoni et al., 2018.
In order to understand the contribution of the environment around the GTP α­bond
moiety, we mutated the glutamic acid residue of the GGDEF signature (Glu890),
involved in the coordination of the second metal ion which bridges the α­PhO group
in the monomer­A (Fig. 21). The PDE activity of the DUAL E890A was
characterized kinetically in presence and absence of GTP. Interestingly, the
dependence of V0 on substrate concentration yields a bell­shaped curve, indicative
of substrate inhibition (Fig. 23A), with a Ki for c­di­GMP close to the apparent KM
(17.8 vs 9.6 µM, with GTP) (Table III). The mutant is still able to respond to GTP,
but above 10 µM c­di­GMP, E890A is not able to maintain the PDE activation
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triggered by GTP and the turnover drops significantly ~100 sec after substrate
addition (Fig. 23B). Moreover, the binding of GTP to DUAL E890A does not alter
the c­di­GMP binding to EAL domain, while this effect is clearly shown by the
wild­type DUAL protein (Fig. 23C). This last property is not due to changes in GTP
affinity, which is not significantly altered in the mutant E890A (Fig. 23D).
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Figure 23. The GGDEF E890A mutation affects the phosphodiesterase activity. (A) The initial
rate of PDE kinetics of E890A carried out in the presence of GTP was plotted as a function of c­di­
GMP concentration and compared to that of DUAL (empty and red circles, respectively). Mutant
kinetic data were fitted with substrate inhibition equation. (B) Time­course of PDE kinetics obtained
at different c­di­GMP concentrations with DUALWT or E890A (red and black traces, respectively).
(C) Titration profile of the binding of E890A with MANT­c­di­GMP, both in the presence or in the
absence of excess GTP (black or open circles, respectively); the GTP does not increase the
equivalents of MANT­c­di­GMP bound, as observed in the wild­type protein (red circles). (D)
Titration profile of the interaction of E890A to MANT­GTP (open circles). The profile superposes
with that of the wild­type protein (red circles); the same profile was observed in the presence of c­di­
GMP (black circles). The Y­axis is the % of FRET signal at 430 nm considering the plateau value as
100 %. Figures adapted from Mantoni et al., 2018.
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The kinetic properties of E890A mutant resembles previously characterized kinetic
behaviours of mutations localized in the dimerization helix of other EAL PDEs; in
these cases, the substrate inhibition profile was due to the presence of c­di­GMP
bound to one monomer, which negatively affected the catalytic efficiency of the
other EAL monomer (Rao et al., 2009). We propose that the effect of the E890
mutation is propagated to the EAL/EAL interface, altering the PDE kinetic
behaviour. This is the first evidence of a mutation in the GGDEF signature affecting
the EAL/EAL crosstalk, resulting in uncoupling of GTP binding and PDE
activation. Moreover, the kinetic profile of this E890A mutant suggests that the
EAL/EAL dimerization is one of the step occurring during the GTP­dependent
protein activation and this strongly supports our activation model.
4.6 Structure­based allosteric model of GTP­dependent activation of RmcA.
Structural data indicate that DUAL shows two different conformational states
associated by a low and high PDE activities. Specifically, the DUAL monomers are
characterized by a different bending of the hinge helix connecting the GGDEF and
EAL domains (Fig. 19A) suggesting that the ON→OFF transition likely involves
the rearrangement from an elongated to a compact conformation. To mechanistically
describe the conformational transition resulting in the allosteric activation of
DUAL, Prof. Paiardini (‘La Sapienza’ University of Rome) modelled two
hypothetical fully ON and OFF conformations of RmcA (Fig. 24), using our
structural data and the structure of the homologous protein MorA (~65% sequence
identity; Phippen et al., 2014), solved as a symmetric dimer.
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Figure 24. GTP­induced PDE activation. (A) Comparison of the symmetric dimers of the DUAL
ON model (derived form the structure of MorA, green) and the DUAL OFF model obtained by NM
analysis starting from the structure of monomer­A (pink). (B) Model of one monomer in the open
(ON) conformation. The hinge helix is in an elongated conformation separating the GGDEF from the
EAL domain. In this ON conformation Arg980 is in close contact with both Asp1038 and Glu1039.
(C) Model of one monomer in the closed (OFF) state. The GGDEF and the EAL domains are in close
proximity and Arg980 makes contacts with both the GTP binding site (highlighted) and the EAL
domain at the level of α1. Figures adapted from Mantoni et al., 2018.
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According to the OFF and ON models, the α1­helix of the EAL domain in
monomer­A is closer to the GTP binding site with respect to monomer­B,
suggesting that GTP binding likely triggers the reorganization of the neighboring
residues in the GTP binding site, inducing the conformational OFF→ON switch. In
addition, the residue Arg980, located at the centre of the hinge helix, is involved in
contacts with both the GGDEF and EAL domains, linking their interactions only in
the OFF state (Fig. 24C). In our model, the GTP binding induces a rearrangement of
the Arg980­mediated GGDEF­EAL domains contacts likely destabilizing the OFF
state and leading the opening of the DUAL module. In addition, Arg980 can also
stabilize the ON state, via its interactions with residues Glu1038 and Asp1039 of the
EAL domains (Fig. 24B). In agreement with this model, GTP “unlocks” the EAL
domains allowing their dimerization and activation, via a large conformational
change of the hinge helix (Fig. 24A). We mutated the Arg980 residue likely
involved in stabilizing both the OFF and the GTP­derived ON conformations, in
order to assess this mechanistic model. Interestingly, the DUAL R980S mutant
shows a GTP­independent PDE activity which is higher than the catalytic activity of
the GTP­free wild­type DUAL (Fig. 25). This data indicates that the substitution of
this residue uncouples GTP binding from enzyme activation. In the absence of GTP,
the OFF→ON equilibrium of the wild­type mainly populates the OFF state thus
accounting for the low basal activity observed; on the other hand, the R980S
mutation shifts this equilibrium to favour the ON state likely by destabilizing the
OFF conformation. Despite this, the R980S mutant PDE activity is slightly lower
than that of the wild­type protein in the presence of GTP (Fig. 25).
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Figure 25. Kinetic analysis of GTP activation as suggested by OFF­ON transition model. PDE
activity of 10 µM wild­type (circles), R980S (triangles) and E1038A/D1039A (diamonds) DUAL
carried out in the presence of 60 µM c­di­GMP as substrate with or without 100 µM GTP (empty and
black symbols, respectively). Nucleotide content of each mixture was assayed by RP­HPLC after 30
min of reaction at 25°C. Data are the mean of at least two experiments ±SD. Figure adapted from
Mantoni et al., 2018
This kinetic behaviour could be explained, according to the model, by the fact that
Arg980 is also involved in electrostatic interactions with Glu1038 and Asp1039 in
the ON state, stabilizing the ON conformation. Nevertheless, the GTP insensitive
behaviour of R980S mutant indicates that the Arg980 residue is involved to ‘lock’
DUAL in the OFF state. To further validate our structural hypothesis, we modified
conserved residues involved in stabilizing the ON state, i.e Glu1038 and Asp1039,
which could interact with Arg980 in the ON structure. As expected, in the presence
of excess GTP, this E1038A/D1039A double mutant shows a PDE activity similar to
the R980S mutant, being also in this case clearly lower than that observed in the
GTP­containing wild­type protein. Interestingly, the absence of GTP dramatically
affects the PDE activity of the E1038A/D1039A double mutant, being ~5 folds
lower than the wild­type. These kinetic data suggest that this double mutation shifts
the OFF→ON equilibrium toward the OFF state, in the absence of GTP. These
results clearly show that Glu1038 and Asp1039 residues are involved in stabilizing
the protein in the ON state, probably via their interaction with Arg980.
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Indeed, Arg980 residue loses its contact(s) in the ON conformation in the double
mutant but it can still stabilize the OFF state, explaining the reduced activity of the
E1038A/D1039A double mutant in the absence of GTP.
4.7 RmcA contains a LOV domain. Since RmcA is a complex multidomain hybrid
protein, we tested if the presence of the upstream domain could affect the kinetic
properties and the allosteric control assessed on DUAL conctruct. For this reason, a
construct named LOV­DUAL, encoding the LOV­GGDEF­EAL domains, was
cloned, expressed and purified. Preliminary catalytic experiments performed using
this construct confirmed the presence of the PDE activity and the absence of the
DGC one. In addition, this construct exhibits the GTP­dependent allosteric
regulation of phosphodiesterase activity. Interestingly, LOV­DUAL showed an
higher phosphodiesterase activity, in both presence and absence of GTP, with
respect to DUAL protein. The basal DUAL enzyme rate is 0.09 µM/min with
respect to 0.15 µM/min of LOV­DUAL. On the other hand, when GTP acts as
allosteric regulation the DUAL rate is 0.35 µM/min in contrast to 1.67 µM/min
observed with LOV­DUAL construct. These data confirm the presence of a different
profile of GTP allosteric regulation between the two constructs: in contrast to the
DUAL construct, the GTP positive effect on LOV­DUAL phospodiesterase activity
is significantly higher (~11 fold GTP­mediated enhancement in contrast to ~3.9 fold
enahcement shown by DUAL construct).
At the same time, a bioinformatic analysis, performed by Prof. Paiardini, suggested
that this additional upstream domain, comprising residues 677­795, can be classified
as a specialized PAS domain named Light, Oxygen or Voltage (LOV) (Fig. 10).
Proteins bearing LOV domains are involved in a large variety of signaling pathways
in both prokaryotes and eukaryotes (Taylor and Zhulin, 1999). More in general, Per­
ARNT­Sim (PAS) domain superfamily is involved in several signalling pathways
sensing different stimuli including oxygen gradient, light, metals availability and
cellular redox state (Becker et al., 2011). To fulfill the redox­related biological
functions, PAS domain were found to bind heme and flavins. The core structure of
the LOV domain is composed of a five­stranded antiparallel β­sheet, surrounded by
three short α­helices and several solvent­exposed loops: this structural arrangement
generates a module forming a symmetric dimer with the other LOV domain
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Figure 26. Homology model of RmcA LOV domain. (A) Three dimensional structure of a dimeric
LOV domains. (B) Structural model of a FAD moiety inside the hydrophobic pocket of the LOV
domain. The NRRK signature is known to be involved in FAD binding interacting with flavin
moiety.
4.8 RmcA LOV domain binds FAD. Bioinformatic structural analysis suggested
that RmcA LOV domain could bind flavin cofactors; to probe this hypothesis, we
performed a reconstitution experiment using FAD the LOV­DUAL construct. As
expected, specific FAD binding by the LOV domain of this RmcA construct was
observed (Fig. 27A).
of the adjacent subunit. In addition, in the inner part of a LOV domain there is an
hydrophobic pocket, required for the binding of several organics ligands. LOV
domains are well known to bind flavin cofactors, including FMN or FAD, to sense
light, redox state or voltage modifications, in order to regulate the activity of the
adjacent domains (Fig. 26A); in these domains, the key residue involved in the
binding of the FAD cofactor is the asparagine within the NRRK motif. According to
this in silico analysis, the RmcA region comprising residues 677­795 shows
structural homology to different proteins containing LOV domains, including the
FAD­containing PAS domain of the NifL from Azotobacter vinelandiia (PDB code
2GJ3, sequence identity: 41%) and the redox sensor domain of MmoS from
Methylococcus capsulatus (PDB code 3EWK, sequence identity: 33%). Moreover,
the NRRK motif involved in flavin binding is evolutionarily well conserved in
RmcA (residues 760­764) (Fig. 26B).
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Figure 27. Preliminary evidences of the LOV­FAD interaction. (A) Reconstitution experiments
suggested a physical interaction between the LOV domain and FAD molecule. After an incubation of
LOV­DUAL and DUAL constructs with excess of FAD for 120’ at room temperature, a size
exclusion chromatography was performed to eliminate the unbound ligand. In the inset, absorption
spectra indicated that only the LOV­DUAL construct retained the FAD molecule, as shown by the
double absorbance peak at 350 and 450 nm. (B) FAD Fluorescence Quenching assay was performed
by titrating 0.5 µM FAD with increased amount of LOV or VFT construct (green and red circles,
respectively). FAD emission quenching indicates that LOV domain binds this flavin.
To better describe this binding, we focused on LOV domain only containing
construct. Preliminary experiments indicated that LOV protein is dimeric in solution
and titration fluorescence experiments were carried out to assess the putative
interaction with FAD . In particular we tested the FAD fluorescence quenching upon
the addition of increased amounts of LOV construct (Sengupta et al., 2012). As
expected, the LOV domain is able to interact with FAD molecule, with a
KD=2.84±1.13 µM, while no quenching effect is observed titrating FAD with VFT
construct as negative internal control since it was predicted not to be able to bind
nucleotides (Fig. 27B). To study the binding event involving the RmcA LOV
domain, the previous titrations were repeated using ITC as experimental platform.
LOV domain specifically binds to FAD with a stoichiometry of 0.38 per monomer
and a Kd= 1.6 µM (Fig. 28). The binding stoichiometry suggests that one molecule
of FAD is bound by a LOV dimer and this experimental data is in agreement with
literature on other LOV­containing proteins (Qi et al., 2009). To test the specificity
of this interaction, the titration was carried out also with FMN and pyocyanin: the
binding is specific since no binding events occured with both molecules (Fig. 28).
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Figure 28. RmcA LOV domain binds FAD. The binding of FAD to LOV was tested by ITC
titrating a LOV solution with different amounts of FAD at 25 °C in corrispondent buffer A. In the
lower panel the normalized enthalpy exchange (black squares, reported as Kcal/Mol of injectant) has
been reported as a function of the Molar Ratio between the injectant and the macromolecule. Data
were fitted with the single binding site equation with the Origin software, as provided by the vendor
(continuous line), yielding the following parameters: n=0.38±0.05; Kd=1.6±0.9 µM; ΔH=­5.1±0.8
kcal/mol; ΔS=9.34±0.9 cal/mol/deg. To verify the specificity of binding, LOV was titrated with
Flavin Mononucleotide and Pyocyanin, as indicate in the figure legend, under the same experimental
conditions.
The putative binding of pyocyanin to the RmcA LOV domain was tested since this
phenazine binds the cytoplasmic portion harboured by the homologous protein in P.
aeruginosa PA14 strain (Okegbe et al., 2017).
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Figure 29. PDE activity of LOV­DUAL is affected by GTP and FAD. Time course assay was
performed in both aerobic and anaerobic conditions (panel A and B, respectively). In both conditions,
the rate of the enzyme is positively affected by the presence of GTP, as expected. Interestengly, the
FAD reduces the extent of the GTP­mediated enhancement. In addition, the basal activity of LOV­
DUAL is clearly improved in low oxygen condition.
To asses a putative kinetic effect induced by the FAD binding to the LOV domain,
we tested the LOV­DUAL PDE catalysis in presence of FAD at different redox
state. Indeed, literature data showed that the final output of other LOV/PAS­
containing c­di­GMP metabolizing enzymes depends on the redox resting state of
the bound flavin which can be O2­dependent: for instance, the diguanylate cyclase
activity of AxDGC2 hybrid protein, from Acetobacter xylinum, is increased after the
oxidation of FAD bound to its upstream PAS domain, resulting in an higher c­di­
GMP production in response to oxygen (Qi et al., 2009). To assess the putative
allosteric role of FAD on LOV­DUAL catalysis, we performed a kinetic assay in
aerobic as well as under low oxygen tension conditions (obtained by fluxing
samples with nitrogen to remove excess oxygen).
Despite the confirmed binding between FAD and LOV domain, performing kinetic
experiments using FAD, as sole allosteric putative regulator, has no effect on PDE
activity under both tested conditions (Fig. 29).
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4.10 The GGDEF domain is able to hydrolyse GTP. The concentration of GTP
and c­di­GMP is very different and variable within the bacterial cell, in the sub­mM
range and in the low µM range, respectively (Christen et al., 2005 ; Simm et al.,
2004 ; Weinhouse et al., 1997). Due to the cellular concentration of GTP, the DUAL
superdomain of RmcA could be predominantly in the ON state. To assess if DUAL
activity may vary according to the different levels of the two nucleotides relative to
the protein, we repeated the PDE kinetic assays on DUAL with GTP at higher
protein concentration (8 µM DUAL rather than 1 µM, using the buffer optimized for
PDE) to evaluate if the GTP effect is unchanged. Under these conditions, the PDE
activity is not affected, but a novel chemical species populates, corresponding to
GMP as confirmed by mass spectrometry (Fig. 30A). The formation of GMP starts
only when c­di­GMP concentration drops below about 8 µM (Fig. 30B) and
proceeds at 1.8±(0,6) x10­2 min­1. The unexpected GTPase activity of DUAL starts
only when c­di­GMP concentration drops down; thus we tested if this activity
occured also at different c­di­GMP concentrations. We performed the same
experiment with a low c­di­GMP concentration and without the dinucleotide. Under
these conditions, we found that GTP hydrolysis occurs at a greater rate, specifically
at 2.3±(0.4) x10­2 min­1 with a low c­di­GMP concentration and at 3.9±(0.6) x10­2
min­1 without c­di­GMP (Fig. 30C). These data suggest that the unexpected GTPase
reactivity is negatively affected by the starting amount of c­di­GMP which in turn
affects the PDE time course.
Interestingly, the phosphodiesterase reaction in presence of both GTP and FAD as
allosteric regulators leads to a reduced turnover. The FAD­dependent inhibition
occurs in both aerobic and anaerobic conditions to a similar extent (~3.6 in aerobic
condition and ~3.3 fold in low oxygen environment) (Fig. 29). These data suggest
that the FAD cofactor works as an allosteric inhibitor of the GTP­mediated
phosphodiesterase enhancement. In agreement with the bioinformatic structural
model, FAD specifically binds to the LOV domain of RmcA and this interaction
triggers a clear reduction of the phosphodiesterase activity of LOV­DUAL construct
only when the latter is bound to the GTP allosteric regulator.
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Figure 30. The GTPase activity of DUAL. (A) Characterization of the GTPase activity of DUAL;
HPLC­MS chromatogram (black) and HPLC­DAD chromatogram (grey) of the nucletoide content,
monitored at 250 nm wavelength, of DUAL reaction mixture. (B) Nucleotides content at different
times of the catalytic reaction carried out with 8 µM DUAL in experimental condition optimized for
GTPase activity (GMP, squares; c­di­GMP, triangles; pGpG, circles). GTP content has not been
reported since its peak overlaps with those of buffer. (C) Time­course of the GTPase reaction
performed with 8 µM DUAL, in presence of different amounts of c­di­GMP or in absence of it (as
indicated in figure legend), in experimental condition optimized for GTPase activity.
In order to exclude the possibility that this unusual GTPase activity could be due to
an experimental artifact associated with the RmcA DUAL construct, we tested the
presence of GTPase activity using the LOV­DUAL construct. As expected, also this
RmcA­derived construct converts GTP to GMP and this GTPase activity decreases
when c­di­GMP is present (Fig. 31). In addition, we observed that products
corresponding to pGpG and c­di­GMP accumulate when the enzyme is incubated
with GTP as sole substrate. This data indicates that the construct, only under these
kinetic experimental conditions, shows a limited diguanylate cyclase activity,
producing c­di­GMP via the GGDEF domain which is then degraded to pGpG by
the EAL one. A possible explanation of this kinetic behaviour is that both the greater
amount of LOV­DUAL protein promoted the DGC random competent dimerization
of the GGDEF domains likely responsible for the production of c­di­GMP (Fig.
31A).
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Figure 31. LOV­DUAL shows a GTPase activity. (A) RP­HPLC Chromatograms confirm that 8
µM LOV­DUAL, incubated with GTP as only substrate, produces GMP. The GTPase activity occurs
also when the enzyme is incubated with both GTP and c­di­GMP. In addition, LOV­DUAL converts
GTP to c­di­GMP showing a DGC activity which is absent in the DUAL construct. (B) Time­course
of GTPase activity performed with 8 µM LOV­DUAL, GTP and with or without c­di­GMP (blu and
red line, respectively), in experimental conditions optimized for GTPase catalysis.
To investigate the main properties of the GTPase activity, different experiments
were performed. Since GMP can be produced from pGpG by a PDE­B activity
(Stelitano et al., 2013), we performed a kinetic assay incubating the DUAL protein
with excess of GTP and pGpG as only substrate. GMP product accumulates only
when the protein is incubated with GTP as starting substrate (Fig. 32A), indicating
that the GMP is not produced by a PDE­B activity. To assess which domain was
responsible of the conversion of GTP to GMP, we tested the GTPase activity using
the both DUAL and EAL­2 constructs: incubating both enzymes with GTP, we
observed that only the DUAL construct is competent for the GTPase activity,
indicating that GGDEF domain is the key domain involved in this unexpected
catalysis (Fig. 32B). In agreement with this result, the GGDEF mutant (DUAL
E890A), despite its sub­µM affinity for GTP, is unable to convert this nucleotide in
GMP, likely because the Glu890 residue is also involved in GTP hydrolysis (Fig.
32B). In addition, we observed that the GTPase activity required either Mg2+ or
Mn2+ while it is abolished by the presence of other bivalent cations, including Zn2+
and Ca2+ (Fig. 32C).
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Figure 32. Properties of GTPase activity. (A) HPLC­RP chromatograms revealed that the GMP is
specifically produced starting from GTP (blue line) as substrate since no GMP accumulates when
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pGpG is used as substrate (red line). This indicates that GMP is not produced by a PDE­b activity of
DUAL construct. (B) HPLC­RP chromatograms indicates that the GGDEF domain of DUAL is
responsible for the production of GMP (green line) since EAL­2 construct is unable to degrade GTP
(red line) and that no GMP accumulates when GGDEF signature is mutated (E890A) (blue line). (C)
GTPase reaction was performed incubating 10 µM DUAL in a reaction solution optimized for
GTPase catalysis containing different divalent ions: the GGDEF domain requires either Mn2+ or
Mg2+ or both (blue, orange and yellow bar, respectively) for its GTPase activity.
4.11 GGDEF uncompetent dimerization promotes GMP production. If this
background reactivity is a general feature of the GGDEF domains, it could bias
kinetic studies describing GGDEF­containing proteins; therefore the establishment
of the proper kinetic conditions is required for rigorous studies of this versatile
domain. In order to deeply establish the kinetic property of this domain, we focused
our attention on several GGDEF containing enzymes. The GTPase activity of
DUAL could be ascribed to an intrinsic reactivity of the 'monomeric' GGDEF
domain since the physiological DGC reaction requires not only the dimerization of
the GGDEF domains but also the facing of the two active sites in order to produce
c­di­GMP starting from two molecules of GTP. In order to assess if the oligomeric
state of GGDEF domains could be involved in GTPase activity, we probed the
presence of this reactivity on two different DGCs: PleD from C. crescentus and the
GGDEF containing portion of YfiN, from P. aeruginosa, an inactive truncated
version purified as monomer.
The diguanylate cyclase activity of PleD requires the dimerization of GGDEF
domains and this conformational process can be induced in vitro by adding the
chemical activator beryllium fluoride (Fernicola et al., 2016). To test the possibility
that GGDEF shows GTPase activity when the physiological diguanylate cyclase can
not occur, we performed the kinetic assay with and without this activator. As
expected, during its diguanylate cyclase activity PleD, c­di­GMP accumulates while
no GMP production is detected (Fig. 33A and 33B). In agreement with our
hypothesis, when the productive dimerization of the GGDEF domains, necessary for
the DGC activity of PleD, was inhibited by the absence of BeCl2, GMP accumulates
from GTP while no significant c­di­GMP production is observed (Fig. 33A and
33B). To confirm that an incompetent GGDEF domain can show an unusual
GTPase activity, we tested the GGDEF containing construct of YfiN inactive as
diguanylate cyclase because this monomeric form is unable to dimerize during
69
C­di­GMP
GTP
GMP
A
C GTP
GMP
B
D
Figure 33. The GGDEF domain of other DGCs is able to produce GMP. (A) HPLC­RP
chromatograms of PleD­mediated diguanylate cyclase reaction. Catalytic reaction was carried out
either using PleD enzyme activated as DGC by BeCl2 (continuous lines) or with the inactivated form
of the enzyme, which was obtained by not adding BeCl2 (dotted lines). (B) Time course of both PleD
DGC and GTPase activities (red and blue lines, respectively). (C) HPLC­RP chromatograms of YfiN
GTPase activity. In particular the GTPase activity of YfiN shows a clear lag­phase starting to
accumulate GMP after 60 minutes (continuous red line). (D) Time course of YfiN GTPase reaction.
Aliquots of the reaction were stop at different times (30­60­120 minutes) and they were analyzed as
described above in Materials and Methods chapter.
turnover (Giardina et al., 2013). As expected, the kinetic data clearly shows that the
inactive GGDEF domain of YfiN starts accumulating GMP without any production
of c­di­GMP (Fig. 33C and 33D). These results indicate that the GGDEF domain
shows a unusual GTPase activity occurring when the main physiological DGC
activity cannot take place due to the inhability to form the active dimer caused by
allosteric constrains, as in PleD, or domain truncation, as in YfiN.
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CONCLUSIONS
In the last years, the importance of the bacterial second messenger c­di­GMP as key
player regulating biofilm formation and dispersal raised up. The large number of
groups currently studying this messenger allowed to unveil the general properties of
enzymes, receptors and effectors involved in c­di­GMP signalling. However, few
biochemical data describing the role of the GGDEF­EAL hybrid proteins in c­di­
GMP homeostasis are available. In addition, few biological data describing how
environmental signals control the enzymes involved in the c­di­GMP network itself
are available.
The aim of my PhD was to biochemically characterize a member of GGDEF­EAL
hybrid protein with a putative environmental sensor domain in order to both identify
the signalling molecule as well as to describe the final output of this enzyme. This
study has been carried out focusing on the product of the gene RmcA from
Pseudomonas aeruginosa, a multidomain protein composed by a periplasmic
sensory domain, a transmembrane helix, three Per­Arnt­Sim (PAS) domain and one
light, oxygen, or voltage domain (LOV) and finally the GGDEF­EAL catalytic
module. Preliminary bioinformatic structural analysis, carried out by Prof. Paiardini,
suggested that this RmcA could sense the amino acid L­arginine by its N­terminal
sensor domain folding as a VFT domain. In agreement with this bioinformatic
prediction, our results reveal that RmcA VFT domain specifically binds this
nutrients and this interaction triggers an in vivo effect by lowering c­di­GMP levels.
Interestingly, analysis of RmcA homologous sequences indicated that this domain
organization is observed only in Pseudomonas genus belonging bacteria (data not
shown). L­arginine is a versatile metabolite acting as a source of carbon, energy, and
nitrogen since P. aeruginosa metabolizes this amino acid via several enzymes such
as arginine decarboxylase (ADC), dehydrogenase (ADH), succinyl­transferase
(AST, aerobic conditions). In anaerobic condition, the bacterium utilizes this amino
acid by the arginine deiminase pathway (ADI) producing ATP (Lu et al., 2004): the
arginine fermentation allows the bacterium to survive when denitrification does not
occur (Kuroki et al., 2014). Further biochemical and microbiological studies aimed
to assess the molecular mechanism through which the L­arginine binding is
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propagated to the GGDEF­EAL effector domains in RmcA are required. However
these findings describe a novel link between L­arginine metabolism and c­di­GMP
signalling on P. aeruginosa. Both in vivo and the preliminary enzymatic assay on
the full length RmcA protein indicated that this protein works as a
phosphodiesterase. Focusing on the GGDEF­EAL containing region of RmcA, we
confirmed the EAL­dependent phosphodiesterase activity. In addition, we found
that a cross­talk between GGDEF and EAL domains occurs. The GGDEF domain
negatively controls the EAL activity; GTP binding to GGDEF domain releases this
negative inter­domain cross­talk through a large conformational change resulting in
the EAL­EAL dimerization. This is not the first experimental evidence of the role of
GTP as allosteric regulator of EAL activity via the GGDEF domain (An et al., 2010
; Christen et al., 2006). It is important to consider that both GTP and c­di­GMP
nucleotides are key players in bacterial physiology since GTP controls the cell’s
metabolic status while c­di­GMP regulates the planktonic/sessile transition: given
that their metabolic pathways are tightly interconnected, a mutual control is
strategic for bacteria. Within the bacterial cell, the levels of GTP and c­di­GMP are
very different, in the sub­mM and low µM range, respectively (Christen et al., 2005
; Weinhouse et al., 1997 ; Simm et al., 2004). Our in vitro kinetic results indicated
that GTP triggers the maximal PDE activity in the micromolar range which is much
smaller than the millimolar range of GTP levels in bacterial cells: in this scenario
the RmcA GGDEF domain would always be fully occupied by GTP, blocking the
regulatory model described above. However, this discrepancy could be explained by
the possible in vivo regulating roles of the upstream domains, missing in the DUAL
construct of RmcA. To follow this hypothesis, we preliminary described the RmcA
LOV domain. Indeed, in addition to the signal transduction mediated by L­arginine
through the VFT moiety, domain architecture analysis indicates that RmcA contains
a Light, Oxygen or Voltage (LOV) domain, belonging to the PAS superfamily,
upstream the GGDEF­EAL region. LOV domains are known to bind flavin cofactor
(FMN or FAD) to perceive light, redox or voltage modifications, in order to control
the activity of their adjacent domains. We confirmed the binding of the RmcA LOV
domain to the FAD molecule, and showed that this interaction triggers, in vitro, a
kinetic effect on the downstream catalytic region regardless the oxygen availability.
73
Indeed, experimental data suggests that FAD works as an allosteric inhibitor of the
GTP­dependent enhancement of the LOV­DUAL phosphodiesterase activity and
thus further biochemical studies will be required to understand the molecular
mechanism behind this inhibition. In particular, there is the possibility that, under
our kinetic setup, different FAD redox states are not fully populated, suggesting that
kinetic characterization of LOV­DUAL construct will have to be carried out in the
presence of redox agents. In addition, structural experiments will be carried out in
order to assess if FAD molecule controls the accessibility of GTP to GGDEF
binding site, thus showing an upstram regulation of the GGDEF domain. All these
results describe a multi­level regulation controlling the activity of RmcA hybrid
protein: this enzyme senses both the environmental state (i.e nutrients availability)
and the cellular state (redox power and energetic state) finely tuning the c­di­GMP
metabolism.
Additional important finding emerged from these studies: a novel unusual GTPase
activity GGDEF­mediated was kinetically described. This kinetic property was
observed in GGDEF domains belonging to DGCs and RmcA hybrid protein: in
DGCs this side effect activity takes place when the main diguanylate cyclase
activity does not occur while in the tested hybrid protein the GTPase activity seems
to compete with the PDE one, overcoming it when the c­di­GMP concentration
drops down. Regardless the biological relevance of this unusual GGDEF dependent
GTPase activity, it is important to consider the latter one when performing the
biochemical characterization of the GGDEF containing enzymes.
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